Skip to main content
SpringerLink
Log in
Book cover

Rauschdrogen pp 7–294Cite as

Psychodysleptica

  • Chapter

  • 1539 Accesses

Auszug

Vorbemerkung: Die Zusammenfassung psychotroper 1 Stoffe 2 unterschiedlichster chemischer Struktur und Anwendungsformen unter Oberbegriffen erfolgt in diesem Buch in erster Linie im Hinblick auf vergleichbare durch sie ausgelöste psychische Wirkungen.

Zu diesem Begriff vgl. unter dem Stichwort „psychoaktiv“ in Anhang A. Bei der ganz überwiegenden Mehrzahl der psychotropen Stoffe handelt es sich zwar um organische Verbindungen, zu anorganischen Stoffen, die vergleichbare Effekte hervorbringen, vgl. jedoch z.B. unter dem Stichwort „Droge“ in Anhang A.

Vgl. zum Stichwort „Stoff“ in Anhang A.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abel EL (1971) Marihuana and memory: acquisition or retrieval? Science 173:1038–1040

    Article  Google Scholar 

  • Abel EL (1976) The scientific study of marihuana. Hall, Chikago

    Google Scholar 

  • Abelson PH (1968) LSD and marihuana. Science 159:89–97

    Google Scholar 

  • Aberle D (1966) The Peyote religion among the Navaho. Aldine, Chikago

    Google Scholar 

  • Ablon SL, Goodwin FK (1974) High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients. Am J Psychiatry 131:448–453

    Google Scholar 

  • Abood LG, Biel JH (1962) Anticholinerge Psychotomimetica. Int Rev Neurobiol 4:217–273

    Google Scholar 

  • Adams AJ et al. (1975) Alcohol and marihuana effects on static visual acuity. Am J Ophthalmol 52:729–735

    Google Scholar 

  • Agosti V, Nunes E, Levin F (2002) Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 28:643–652

    Article  Google Scholar 

  • Agurell S et al. (1971) Metabolism of 7-hydroxy-delta-1-(16)-THC and CBN. Acta Pharm Suec 8

    Google Scholar 

  • Agurell S, Gustafson B, Holmstedt B (1973) Quantitation of Δ1-tetrahydrocannabinol in plasma from cannabis smokers. J Pharm Pharmacol 25:448–554

    Google Scholar 

  • Agurell S, Dewey WL, Willette RE (eds) (1984) The cannabinoids: chemical, pharmacologic and therapeutic aspects. Academic Press, New York

    Google Scholar 

  • Agurell S, Halldin M, Lindgren JE et al. (1986) Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38:21–43

    Google Scholar 

  • Ahmedzai S, Carlyle DL, Calder IT, Moran F (1983) Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Brit J Cancer 46(5):657–663

    Google Scholar 

  • Akinloye BA, Court WE (1981) The alkaloids of Rauwolfia volsinii. J Etnopharmacol 4:99–109

    Article  Google Scholar 

  • Algeier-Föll R (1991) Cannabis und Verkehrstauglichkeit (Literaturüberblick). Zentralbl Rechtsmed 35:614–623

    Google Scholar 

  • Alpert R (1969) Psychedelics and sexual behavior. J Sex Res 5:50–54

    Article  Google Scholar 

  • Alt A, Reinhardt G (1996) Speiseöle auf Hanfbasis und ihr Einfluß auf die Ergebnisse von Urin-und Blutanalysen. Blutalkohol 33:347–356

    Google Scholar 

  • Alt A, Reinhardt G (1997) Nahrungsmittel auf Hanfbasis und deren forensische Bedeutung. Blutalkohol 34: 286–293

    Google Scholar 

  • Amendt G (1974) Haschisch und Sexualität. Enke, Stuttgart

    Google Scholar 

  • Anderson EF (1969) The biogeography, ecology, and taxonomy of lophophora (cactacea). Brittonia 21/4:229–310

    Article  Google Scholar 

  • Andersson PG (1975) Ergotamine headache. Headache 15:118–121

    Article  Google Scholar 

  • Andréasson S, Engström A, Allebeck P, Rydberg U (1988) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 11:1483–1486

    Google Scholar 

  • Andrews G, Vinkenoog S (eds) (1968) The book of grass. Grove, New York

    Google Scholar 

  • Angst J (1970) Halluzinogen-Abusus. Schweiz Med Wochenschr 100:710–715

    Google Scholar 

  • Angst J, Dittrich A, Woggon B (1972) Psychologische und klinische Aspekte des Cannabismißbrauchs. Z Allgemeinmed 48:94–99

    Google Scholar 

  • Anonymus (1981) Cannabis im Garten. Volksverlag, Linden

    Google Scholar 

  • Ashton CH (2001) Pharmacology and effects of cannabinoids: a brief review. Br J Psychiat 178:101–106

    Article  Google Scholar 

  • Bachmann EW, Hoffmann AA, Waser PG (1979) Identification of Δ9-tetrahydrocannabinol in human plasma by gas chromatography. J Chrom 178:320–323

    Article  Google Scholar 

  • Bailey DN (1979) Phencyclidine abuse. Am Clin Pathol 72:759

    Google Scholar 

  • Baker AA, Lukas EG (1969) Some hospital admissions associated with cannabis. Lancet 1:148–160

    Article  Google Scholar 

  • Balster RL, Chait LD (1976) The behavioral pharmakology of phencyclidine. Clin Toxicol 9/4:573–578

    Google Scholar 

  • Barnes C, Fried PA (1974) Tolerance to delta-9-THC in adult rats with differential delta-9-THC exposure with immature or during early adulthood. Psychopharmacology (Berlin) 34:181–190

    Article  Google Scholar 

  • Battegay R, Bäumler J, Gnirss F, Ladewig D (1969) Zur Drogenabhängigkeit vom Typ Cannabis (Haschisch, Marihuana). Schweiz Med Wochenschr 99:965–971

    Google Scholar 

  • Battersby AR (1963) Recent researches on indole alkaloids. Pure Appl Chem 6:471–488

    Google Scholar 

  • Bauer W (Hrsg) (1980) Fliegenpilz — Fleisch der Götter. Schamanistische Ekstasekulte in Europa. Trikont, München.

    Google Scholar 

  • Baumgartner AM, Jones PF, Black CT (1981) Detection of phencyclidine in hair. J Forensic Sci 26:576–581

    Google Scholar 

  • Baumgartner WA (1986) Analysis of tetrahydrocannabinol (THC) in hair. US Navy Rehabilitation Center Study, Final Report, pp 1–16

    Google Scholar 

  • Beaubrun MH, Knight F (1973) Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. Am J Psychiatry 130: 309–311

    Google Scholar 

  • Beautrais AL et al. (1999) Cannabus abuse and serious suicide attempts. Addiction 94(8): 1155–1164

    Article  Google Scholar 

  • Behr H-G (oJ) Haschisch-Kochbuch. Volksverlag, Linden

    Google Scholar 

  • Behr H-G (1982) Von Hanf ist die Rede. Sphinx, Basel

    Google Scholar 

  • Below E, Rosenstock S, Lignitz E (2005) Hanfprodukte auf dem deutschen Lebensmittelmarkt. THC-Gehalt und forensische Bedeutung. Blutalkohol 42:442–449

    Google Scholar 

  • Benecke M (1997) TECHNO — Eine verwirrende Partykultur. Kriminalistik 7:475–479

    Google Scholar 

  • Benitez F (1968) En la tierra màgica del peyote. Biblioteca Era, Serie Popular, Mexiko

    Google Scholar 

  • Berghaus G, Meininger I (Hrsg) (1998) Cannabis im Straßenverkehr. Gustav-Fischer, Stuttgart, Jena, Lübeck, Ulm

    Google Scholar 

  • Berhardson G, Gunne LM (1972) 46 cases of psychoses in cannabis abusers. Int J Addict 7:9–16

    Google Scholar 

  • Beringer K (1927) Der Meskalinrausch. Springer, Berlin (Neudruck 1969)

    Google Scholar 

  • Beringer K (1932) Zur Klinik des Haschischrausches. Nervenarzt 5: 30–41

    Google Scholar 

  • Berkefeldt K, Löhrer F (1998) Biogene Drogen. Kriminalistik 8–9: 563–566

    Google Scholar 

  • Betz P, Janzen J, Roider G et al (1991) Psychopathologische Befunde nach Aufnahme von Inhaltsstoffen heimischer Nachtschattengewächse. Archiv f Kriminol 188:175–182

    Google Scholar 

  • Bialos DS (1970) Adverse marijuana reactions: A critical examination of the literature with selected cas material. Am J Psychiatry 127:819–823

    Google Scholar 

  • Binder MA (1981) Haschisch und Marihuana — was der Arzt über Cannabinoide wissen sollte. Dtsch Ärztebl 78:117–120

    Google Scholar 

  • Bischoff WH (1966) The exstasy drugs. Univ Circle Press, Delray Beach

    Google Scholar 

  • Blaine JD, Meacham MP, Janowsky DS, Schoor M, Bozetti LP (1976) Pharmacology of marijuana. Raven, New York

    Google Scholar 

  • Blevins D, Regan JD (1976) Delta-9-THC. Effect an macromolecular synthesis in human and other mammalian cells. In: Nahas GG, Paton WOM, Idänpää-Heikkilä JF (eds) Marihuana: Chemistry, biochemistry, and cellular effects. Springer, New York, pp 32–68

    Google Scholar 

  • Boettcher C (1866) Über die Anwendung des indischen Hanfes in der Psychiatrie. Berl Klin Wochenschr 3

    Google Scholar 

  • Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL (2002) Dose-related neurocognitive effects of marijuana use. Neurology 59:1337–1343

    Google Scholar 

  • Bonnie RJ, Whitebread CH (1978) The marihuana conviction. Univ Press of Virginia, Charlottesville

    Google Scholar 

  • Bogusz M, Schmidt G (1990) Forensisch-toxikologische Aspekte des Cannabis-Missbrauchs. Zbl Rechtsmed 33:383–398

    Google Scholar 

  • Borg J, Gershon S, Alpert M (1975) Dose effects of smoked marihuana on human cognitive and motor function. Psychopharmacologia 42:211–218

    Article  Google Scholar 

  • Boroffca A (1978) Cannabis und Psychiatrie. Suchtgefahren 24:28–37

    Google Scholar 

  • Bost RO (1988) 3,4-Methylendioxymethamphetamine (MDMA) and other Amphetamine Derivats. J Forensic Sci 33/2:576–587

    Google Scholar 

  • Bové FJ (1970) The story of Ergot. Karger, Basel

    Google Scholar 

  • Bovens MG, Hansjakob T (2002) Rechtliche Neuregelung von halluzinogenen Pilzen. Kriminalistik 7/471–477

    Google Scholar 

  • Bowman M, Pihl R (1973) Cannabis: Psychiological effects of chronic heavy use. Psychopharmacology (Berlin) 29:159–170

    Article  Google Scholar 

  • Bram S, Bracet P (1976) Inhibition of proliferation and differentation of D. dicoideum amoebae by THC and cannabinol. In: Nahas GG, Paton WOM, Idänpää-Heikkilä JF (eds) Marihuna: Chemistry, biochemistry, and cellular effects. Springer, New York, pp 116–138

    Google Scholar 

  • Bratzke H, Klug E (1985) Gewaltdelikte und LSD-Rausch. Beitr gerichtl Med 43:179–186

    Google Scholar 

  • Braude MC, Szara S (eds) (1976) Pharmacology of marihuana. Raven, New York

    Google Scholar 

  • Brawley P et al. (1972) Pharmacology of hallucinogens. Pharmacol Rev 24

    Google Scholar 

  • Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ et al. (2002) Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol 42(11 Suppl.):82–89

    Google Scholar 

  • Bremkamp S (1980) PCP: Learning to like a dangerous drug. J Psychedelic Drugs 12/2: 171–172

    Google Scholar 

  • Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y (1996) The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Int J Clin Pharmacol Ther 34:446–452

    Google Scholar 

  • Brickenstein R (1971) Gefahren der Cannabisdrogen für Heranwachsende. Z Allgemeinmed 47:846–851

    Google Scholar 

  • Bromberg W (1934) Marihuana intoxication. Am J Psychiatry 91:303–340

    Google Scholar 

  • Bromberger A, Goerke R, Weinmann W (1999) Bestimmungsgrenzen für den Nachweis von Cannabinoiden im Serum. Rechtsmed 9:131–137

    Article  Google Scholar 

  • Bron B (1979) Psychopathologisches Erscheinungsbild und klinische Bedeutung des Horror-Trips. Suchtgefahren 25/4:167–176

    Google Scholar 

  • Bron B (1987) Drogeninduzierte Intoxikationen und Psychosen. Fortschr Med 4:73–76 und 5:94–96

    Google Scholar 

  • Brown FC (1972) Halluzinogenic drugs. Thomas, Springfield/Il

    Google Scholar 

  • Brunner TF (1977) Marijuana in Ancient Greece and Rome ? J Psychedelic Drugs 9/3:221–225

    Google Scholar 

  • Bschor F (1950) Marihuana. Kriminalistik 4:19–24

    Google Scholar 

  • Budney AJ, Novy PL, Hughes JR (1999) Marijuana withdrawl among adults seeking treatment for marijuana dependence. Addiction 94:1311–1321

    Article  Google Scholar 

  • Bull J (1971) Cerebral atrophy in young Cannabis smokers. Lancet 11: 1420–1448

    Article  Google Scholar 

  • Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin (2000) BgVV empfiehlt Richtwerte für THC (Tetrahydrocannabinol) in hanfhaltigen Lebensmitteln. BgVV Pressedienst 07/2000 vom 16.3.2000

    Google Scholar 

  • Burns RS, Lerner SE (1976) Phencyclidine: An emerging drug problem. Clin Toxicol 9/4:473–475

    Google Scholar 

  • Burns RS et al. (1978) Cause of PCP-related death. Clin Toxicol 12/4: 463

    Article  Google Scholar 

  • Burroughs W, Ginsberg A (1964) Auf der Suche nach Yagé. Limes, Wiesbaden

    Google Scholar 

  • Burstein S, Kupfer D (1971) Hydroxylation of trans-delta-l-THC by hepatic microsomal oxygenase. Ann NY Acad Sci 191:32–37

    Article  Google Scholar 

  • Butler JL, Gaines LS, Lenox JR (1976) Effects of marijuana expectation and suggestibility an cognitive functioning. Percept Mot Skills 42:1059–1065

    Google Scholar 

  • Bye RA jr (1979) Hallucinogenic plants of the tarahumara. J Ethnopharmacol 1:23–48

    Article  Google Scholar 

  • Caldwelle DF et al. (1969) Auditory and visual threshold effects of marihuana in man. Percept Mot Skills 29:755–759

    Google Scholar 

  • Callaway CA, Johnson MP, Gold LH, Nichols DE, Geyer MA (1991) Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacol 104(3):293–302

    Article  Google Scholar 

  • Callaway CA, Geyer MA (1992) Stimulant effects of 3,4-methylendioxymethamphetamine in the nucleus accumbens of rat. Eur J Pharmacol 214(1):45–51

    Article  Google Scholar 

  • Campbell AMG, Evans M, Thomson JLG, Williams MJ (1971) Cerebral atrophy in young cannabis smokers. Leancet 11:1219–1224

    Article  Google Scholar 

  • Campbell AMG, Evans M, Thomson JLG, Williams MJ (1972) Cerebral atrophy in young cannabis smokers. Lancet 1:202 ff

    Google Scholar 

  • Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. Br Med J 323:13–16

    Article  Google Scholar 

  • Carlin AS, Post RD (1971) Patterns of Drug Use Among Marihuna Smokers. JAMA 218:867–868

    Article  Google Scholar 

  • Carlin AS, Trupin EW (1977) The effect of long-term chronic marijuana use on neuropsychological functioning. Int J Addict 12:36–48

    Google Scholar 

  • Carlin AS et al. (1972) Social facilitation of marihuana intoxication. J Abnorm Psychol 80:132–140

    Article  Google Scholar 

  • Carlson KA (1979) PCP from the other side. J Psychedelic Drugs 11/3: 231–238

    Google Scholar 

  • Cashman J (1968) LSD, die Wunderdroge. Ullstein, Frankfurt am Main

    Google Scholar 

  • Casswell M (1975) Cannabis and temporal desintegration on experienced and naive subjects. Science 179:803–805

    Article  Google Scholar 

  • Castillo JD, Anderson M, Rubboton GM (1975) Marijuana, Absinthe and the Central Nervous System. Nature 253:365–366

    Article  Google Scholar 

  • Casto D (1970) Marijuana and the assassins, an etymological investigation. Br J Addict 65:219–225

    Article  Google Scholar 

  • Cervantes J, Clarke RC (1993) Marihuana drinnen. Alles über den Anbau im Haus. Sensi Seeds, Ansterdam

    Google Scholar 

  • Chait LD, Fischman MW, Schuster CR (1985) „Hangover“ effects the morning after marijuana smoking. Drug Alcohol Depend 15:229–238

    Article  Google Scholar 

  • Chan GC, Hinds TR, Impey S, Storm DR (1998) Hippocampal neurotoxicity of δ9-tetrahydrocannabinol. J Neurosci 18:5322–5332

    Google Scholar 

  • Chatterjee A (1953) Rauwolfia alkaloids. Fortschr Chem Organ Naturst 10:390–394

    Google Scholar 

  • Chavalampous KD, Walker KE, Kinross-Wright J (1966) Metabolic fate of mescaline in man. Psychopharm 9:48–63

    Article  Google Scholar 

  • Cherniak L (1979) The great books of hashish. And/Or Press, Berkeley

    Google Scholar 

  • Chiang C-W, Barnett G (1984) Marijuana effect and delta-9-tetrahydrocannabinol plasma level. Clin Pharmacol Ther 36:234–238

    Article  Google Scholar 

  • Childers SR et al. (1994) Effects of Amandamide on Cannabinoid Receptors in Rat Brain Membrane. Biochem Pharmacol 47:711–714

    Article  Google Scholar 

  • Chopra GS (1973) Studies an psycho-clinical aspects of long-term marihuana use in 124 cases. Int J Addict 8:1015–1026

    Google Scholar 

  • Clark LD, Nakashima EN (1968) Experimental stufies of marihuana. Am J Psychiatry 125:379–384

    Google Scholar 

  • Claussen U, Korte F (1966) Herkunft, Wirkung und Synthese der Inhaltsstoffe des Haschisch. Naturwissenschaften 21:541–546

    Article  Google Scholar 

  • Co BT, Goodwin DW, Gado M, Mikhael M, Hill SY (1977) Absence of cerebral atrophy in chronic cannabis users. JAMA 237/12:1229–1230

    Article  Google Scholar 

  • Cohen S (1965) The beyond within — The LSD story. Atheneum, New York

    Google Scholar 

  • Cohen S (1966) A classification of LSD complications. Psychosomatics 7:182–186

    Google Scholar 

  • Cohen S (1967) Psychotomimetics agents. Ann Rev Pharm 7:301–318

    Article  Google Scholar 

  • Cohen S (1982) Cannabis and sex: Multifacted paradoxes. J Psychedelic Drugs 14/1–2:55–58

    Google Scholar 

  • Colbach E (1971) Marijuana use by GI’s in Vietnam. Am J Psychiatry 128:204–207

    Google Scholar 

  • Coleman JH, Tacker HL, Evans WE, Lemmi H, Britton EL (1976) Neurological manifestations of chronic marihuana intoxication. Part 1: Paresis of the fourth cranial nerve. Dis Nerv Syst 37:29–38

    Google Scholar 

  • O’Connor JE, Rejent TA (1981) EMIT cannabinoid assay: confirmation by RIA und GC/MS. J Anal Tox 6:168–173

    Google Scholar 

  • Conrad B III (1988) Absinthe: History in a Bottle. Chronicle Books, San Francisco

    Google Scholar 

  • Consroe PF, Man DP (1973) Effects of δ8-and δ9-tetrahydrocannabinol on experimental induced seizures. Life Sci 13:429–439

    Article  Google Scholar 

  • Cooper R (1978) A guide to British psilocybin mushrooms. Hassle Free Press

    Google Scholar 

  • Crawford WJ, Merritt JC (1979) Effects of tetrahydrocannabinol on arterial and intraocular hypertension. Int J Clin Pharmacol Biopharm 17:191–196

    Google Scholar 

  • Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacol 153:373–379

    Article  Google Scholar 

  • Crowley TJ, Macdonald MJ, Whitmore E, Mikulich SK (1998) Cannabis dependence, withdrawel, and re-inforcement effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 50:27–37

    Article  Google Scholar 

  • Croxford JL (2003) Therapeutic potential of cannabinoids in CNS disease. CNS-Drugs 17(3):179–202

    Article  Google Scholar 

  • DalCason TA (1989) The characterization of some 3,4-methylendioxyphenylisopropylamine (MDA) analogs. J Forensic Sci 34/4:928–961

    Google Scholar 

  • Daltrup T (1995) Bestimmung von Cannabinoiden. Toxichem u Krimtech 62:21–27

    Google Scholar 

  • Daltrup T, Reudenbach G, Kimm K (1987) Cannabis und Alkohol im Straßenverkehr. Blutalkohol 24:144–155

    Google Scholar 

  • Daltrup T, Käferstein H, Köhler H et al. (2000) Entscheidung zwischen einmaligem/gelegentlichem und regelmäßigem Cannabiskonsum. Blutalkohol 37:39–47

    Google Scholar 

  • Dalterio S, Bartke A (1979) Perinatal exposure to cannabinoids alters male reproductive function in mice. Science 205:1420–1422

    Article  Google Scholar 

  • Darley CF, Tinklenberg JR, Hollister TE et al. (1973) Marihuana and retrieval from short term memory. Psychopharmacol (Berlin) 29: 231–238

    Article  Google Scholar 

  • Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E (2001) Psychological profile of abstinent recreational ecstasy (MDMA) users and significance of concomitant cannabis use. Human Psychopharmacol Clin Experimental 16:627–633

    Article  Google Scholar 

  • Daunderer M (1979) Therapie einer Atropa-belladonna-Vergiftung mit dem Antidot Physostigmin. Med Welt 30:1743

    Google Scholar 

  • Davenport J (1966) Aphrodisiacs and love stimulants. Lyle Stuart, New York

    Google Scholar 

  • Demisch L, Kaczmarczyk P, Seiler N (1978) 3,4,5-Trimethoxybenzoic acid. A new mescaline metabolite in humans. Drug Met Disp 6: 507–509

    Google Scholar 

  • Devane WA et al. (1992) Isolation and Structure of a Brain Constituent that Binds to the Cannabinoid Receptor. Science 258: 1946–1947

    Article  Google Scholar 

  • Diaz JL (1979) Ethnopharmacology and Taxonomy of Mexican psychodysleptic plants. J Psychedelic Drugs 11/1–2:71–101

    Google Scholar 

  • Dieckhöfer K, Goenchea S (1972) Zur Toxizität von Cannabis. 1. Mitteilung. Med Welt 23:779–782

    Google Scholar 

  • Dietz L, Glaz-Sandberg A, Nguyen H, Mikus G, Aderjan R (2007) Zur Kinetik des 11-Nor-9-carboxy-delta-9-tetrahydrocannabinol-glucuronids im Serum und Urin im Menschen. BA 49:50

    Google Scholar 

  • Dittrich A, Hofmann A, Leuner M (Hrsg) (1994) Welten des Bewußtseins. Wissenschaft und Bildung, Berlin

    Google Scholar 

  • Domino EF (1981) Cannabinoids and the cholinergic system. J Clin Pharmacol Suppl 21:149S–255S

    Google Scholar 

  • Domino L, Domino S, Domino EF (1984) Relation of plasma delta-9-tetrahydrocannabinol concentrations to subjective „high“ marijuana users: a review and reanalysis. Academic press, New York

    Google Scholar 

  • Don Castro III (1970) Marihuana and the assassins. Br J Addict 65: 35–39

    Article  Google Scholar 

  • Doorenbos NJ et al. (1971) Cultivation, extraction and analysis of cannabis. Ann NY Acad Sci 191:90–95

    Article  Google Scholar 

  • Dornbusch RL, Abrams R, Fink M (1971) Marijuana, memory and perception. Am J Psychiatry 128:194–197

    Google Scholar 

  • Dowling GP, McDonough ET, Bost RO (1987) „Eve“ and „Ectasy“. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257/12:1615–1617

    Article  Google Scholar 

  • Downer EJ, Fogarty MP, Campbell VA (2001) Delta-9-tetrahydrocannabinol induces the apoptic pathway in cultured cortical neurones via activation of the CB1 receptors. Neuroreport 12(18):2973–3978

    Article  Google Scholar 

  • Downer EJ, Fogarty MP, Campbell VA (2003) Tetrahydrocannabinol-induced neurotoxicity depend on CB1-receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br J Pharmacol 140:547–557

    Article  Google Scholar 

  • Downing J (1986) The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs 18(4):335–340

    Google Scholar 

  • Drasch G, Meyer L von, Roider G, Jägerhuber A (2003) Absolute Fahruntüchtigkeit unter der Wirkung von Cannabis. Vorschlag für einen Grenzwert. Blutalkohol 40:269–286

    Google Scholar 

  • Drasch G, Meyer L von, Roider G, Staack RF, Pauk LD, Eisenmenger W (2006) Unfälle und reale Gefährdung des Straßenverkehrs unter Cannabis-Wirkung. Blutalkohol 43:441–450

    Google Scholar 

  • Eastman JW, Cohen SN (1975) Hypertensive Crisis and Death Associated with Phencyclidine Poisoning. JAMA 231/12:1270–1271

    Article  Google Scholar 

  • Edery H, Soroko D, Kunberg W (1971) Structural requirements for cannabinoid activity. Ann NY Acad Sci 191:139–145

    Article  Google Scholar 

  • Efron DH (1970) Psychotomimetic drugs. Raven. New York

    Google Scholar 

  • Efron D, Holmstedt B, Kline NS (eds) (1967) Ethnopharmacological search for psychoactive drugs. Public Health Serv Publ 1645: 211–216

    Google Scholar 

  • Ehrenreich H, Rinn T, Kunert H, Moeller MR, Poser W et al. (1999) Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacol 142:295–301

    Article  Google Scholar 

  • Einhorn LH, Nagy C, Furnas B, Williams SD (1981) Nabilone, an effective antiemetic in patients reveiving cancer chemotherapie. J Clin Pharmacol 9:1314–1319

    Google Scholar 

  • Eisner B (1994) Ecstasy: The MDMA-Story. Ronin Publishing, Berkeley, CA

    Google Scholar 

  • Eliade M (1956) Schamanismus und archaische Ekstasetechnik. Rascher, Zürich Stuttgart

    Google Scholar 

  • Ellis GM Jr et al. (1985) Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Therap 38:572–578

    Article  Google Scholar 

  • Enßlin HK et al. (1990) Trennung von MDA, MDE, MDMA: Verbindung von AMD-Technik und DC/IR-Koppelung. Toxichem/Krimtech 6/57:164–168

    Google Scholar 

  • Estrada A (1980) Maria Sabina. Botin der heiligen Pilze. Trikont, München

    Google Scholar 

  • Eugster CH (1968) Wirkstoffe aus dem Fliegenpilz. Naturwissenschaften 55:305–313

    Article  Google Scholar 

  • Fabre LF, McLendon D (1981) The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J Clin Pharmacol 21:377–382

    Google Scholar 

  • Farfel GM et al. (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. J Pharmacol Exp Ther 272/2,1:860–867, 11:868–875

    Google Scholar 

  • Farnsworth NR (1968) Halluzinogenic plants. Science 162:96–105

    Article  Google Scholar 

  • Feldman HW et al. (eds) (1979) Angel dust: An ethnographic study of PCP users. Lexington Books, Lexington/MA

    Google Scholar 

  • Ferdi (Pseudonym) (1996) zu hause züchten. leitfaden für einsteiger. 3. Aufl. Grassberry Productions, Heerlen

    Google Scholar 

  • Fergusson DM, Horwood LJ, Swain-Campbell N (2002) Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 97:1123–1135

    Article  Google Scholar 

  • Feuerlein W (Hrsg.) (1980) Cannabis heute. Bestandsaufnahme zum Haschischproblem. Akademische Verlagsgesellschaft, Wiesbaden

    Google Scholar 

  • Fink DJ, Ashworth B, Brewer C (1972) Cerebral atrophy in young cannabis smokers. Lancet 1:143–147

    Article  Google Scholar 

  • Fischer C, Hatzidimitrion G, Wios J, Kath J, Recautre G (1995) Reorganization of Ascending 5-HT Axon Projections in Animal Previously Exposed to the Recreational Drug MDMA (‘Ecstasy’). J of Neuroscience 8:5476–5485

    Google Scholar 

  • Fischer J, Täschner K-L (1991) Flash back nach Cannabis-Konsum — eine Übersicht. Fortschr Neurol Psychiatr 59:437–446

    Google Scholar 

  • Fisher G, Steckler A (1974) Psychological effects, personality and behavioral changes attributed to marihuana use. Int J Addict 9:101–126

    Google Scholar 

  • Fligiel SEG, Venkat H, Gong H, Tashkin DP (1988) Bronchial pathology in chronic marijuana smokers: a light and electron microscopic study. J Psychoactive Drugs 20:33–42

    Google Scholar 

  • Flom MC, Adams AJ, Jones RT (1975) Marijuana smoking and reduced pressure in human eyes: drug action or epiphenomenon ? Invest Ophthalm 14:52–55

    Google Scholar 

  • Forstenhäusler D (1993) Synthetische Drogen. Kriminalistik 8–9: 533–558

    Google Scholar 

  • Frank M, Rosenthal E (1974) Marijuana Grower’s Guide. And/Or Press, San Francisco

    Google Scholar 

  • Franks HM, Starmer GA, Chesher GB, Jackson DM, Hensley VR, Hensley WJ (1975) The interaction of alcohol and delta-9-tetrahydrocannabinol in man. Effects on psychomotor skills related to driving. Add Res Fond of Ontario, Toronto

    Google Scholar 

  • Frederick DL et al. (1985) Comparison of six cannabinoid metabolite assays. J Anal Tox 9:116–120

    Google Scholar 

  • Frederking W (1955) LSD-25 and mescaline in psychotherapy. J Ment Dis 121:70–77

    Google Scholar 

  • Freedman DX (1963) Psychotomimetic drugs and brain biogenic amines. Am J Psychiatry 119:843–850

    Google Scholar 

  • Fride E, Shohami E (2002) The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. Neuroreport 13(15):1833–1841

    Article  Google Scholar 

  • Fried PA (1977) Behavioral and electroencephalographic correlates of the chronic use of marihuana — a review. Bull Narc 29/2:29–34

    Google Scholar 

  • Fried P, Watkinson B, James D, Gray R (2003) Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. Can Med Ass J 66(7):887–891.

    Google Scholar 

  • Friedberg C (1965) Des Banisteriopsis utilisés comme drogue en Ameriqué du sud. J Agric Trop Bot Appl 12:403–437, 550–594, 729–780

    Google Scholar 

  • Furst PT (1971) Ariocarpus retusus, the „false peyote“ of Huichol tradition. Econ Bot 25/1:182–187

    Google Scholar 

  • Furst PT (ed) (1972) Flesh of the gods: The ritual use of hallucinogens. Prager, New York

    Google Scholar 

  • Furst PT (1976) Hallucinogens and culture. Chandler & Sharp, San Francisco

    Google Scholar 

  • Galanter M, Wyatt R, Lemberger L et al. (1972) Marijuana intocication: Interaction between physiologic effects and subjektive experience. Sciene 176:934–936

    Article  Google Scholar 

  • Gale EN, Guenther G (1971) Motivational factors associated with the use of Cannabis. Br J Addict 13:30–36

    Google Scholar 

  • Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Sci 86:136–147

    Google Scholar 

  • Garrett ER, Hunt CA (1977) Separation and analysis of △1-tetrahydrocannabinol in biological fluids by high-pressure liquid chromatopgraphy and GLC. J Pharm Sci 66:20–26

    Article  Google Scholar 

  • Gautier T (1846) Le club des hachichins. Revue des Deux Mondes

    Google Scholar 

  • Gerhard H (2001) Party-Drugs: Sociocultural and individual background and risks. Int J Clin Pharmacol and Therapeutics 39–8:362–366

    Google Scholar 

  • Gerlach D, Schüling S (1984) Phencyclidin, Hinweise zur Erkennung und Behandlung von PCP-Intoxikationen. Suchtgefahren 30:273–279

    Google Scholar 

  • Gielsdorf W, Klug E (1981) Neues Rauschmittel auf dem Drogenmarkt: 2,5-Dimethoxy-4-bromamphetamin (DOB). Dtsch ApothZ 20:1003–1005

    Google Scholar 

  • Gilmour DG, Bloom AD, Kusum PL, Robbins ES, Maximilian C (1971) Chromosomal aberrations in users of psychoactive drugs. Arch Gen Psychiatry 24:268–272

    Google Scholar 

  • Goenchea S, Dieckhöfer K (1972) Zur Toxizität von Cannabis. 2. Mitteilung. Med Welt 23:1148–1151

    Google Scholar 

  • Goodall CR, Basteyns BJ (1995) A reliable method for the detection, confirmation, and quantitation of cannabinoids in blood. J Anal Toxicol 19:419–426

    Google Scholar 

  • Goode E (1970) The marijuana smokers. Basic, New York

    Google Scholar 

  • Gorman M, Neuss N, Cone NJ (1965) Vinca alkaloids, XVII. Chemistry of catharanthine. J Am Chem Soc 87:93–98

    Article  Google Scholar 

  • Gostomzyk JG, Gewecke M, Eisele G (1971) Vergleichende Untersuchungen zur Verkehrstauglichkeit nach Haschischkonsum und nach einer Kurznarkose. Med Welt 22:1785

    Google Scholar 

  • Gostomzyk JG, Parade P, Gewecke H (1973) Rauschmittelgenuss und Leistungsfähigkeit (Untersuchungen zur Energiebildung unter Haschisch). Z Rechtsmed 73:131–136

    Article  Google Scholar 

  • Gouzoulis-Mayfrank E, Hermle L, Kovar KA, Sass H (1996) Die Entaktogene Ecstasy (MDMA), Eve (MDE) und andere ringsubstituierte Methamphetaminderivate. Nervenarzt 67:369–380

    Google Scholar 

  • Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA et al. (1999) Psychopathological, neuroendocrine and autonomic effects of 3,4-methylen-dioxyethylamphetamine (MDE), psilocybin und d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. Psychopharmacol (Berlin) 142(1):41–50

    Article  Google Scholar 

  • Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S et al. (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurology Neurosurgery Psychiatry 68:719–725

    Article  Google Scholar 

  • Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagen F, Daumann J (2002) Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis. Biological Psychiatry 51(9):766–769

    Article  Google Scholar 

  • Granier M (1962) Native halluzinogene Arzneimittel aus Piptadenia. Bull an Narcotics 17:29

    Google Scholar 

  • Grant BF, Pickering R (1999) The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the National Longitudinal Alcohol Epidemiology Survey. J Subst Abuse Treat 10:255–264

    Google Scholar 

  • Green KS (1984) Discussion of the use of marihuana, ethanol, and other drugs among drivers killed in single vehicle crashes. J Forensic Sci 29:16–21

    Google Scholar 

  • Green K (1975) Marihuana and the eye. Invest Ophthalm 14:261–263

    Google Scholar 

  • Grella CE, Hser YI, Joshi V, Rouds-Bryant J (2001) Drug treatment outcomes for adolescents with co-morbid mantal and substance use disorders. J Nerv Ment Dis 189:384–392

    Article  Google Scholar 

  • Grenn K, Podos SM (1974) Antagonism of arachidonic acid induced ocular effects by delta-tetrahydrocannabinol. Invest Ophthalm 13: 422–429

    Google Scholar 

  • Green AR, Gross AJ, Goodwin GM (1995) Review of the pharmacology of MDMA. Psychopharmacol 119:247–260

    Article  Google Scholar 

  • Green AR, Goodwin GM (1996) Ecstasy and neurodegeneration. Brain Med J 312:1493

    Google Scholar 

  • Green K, Kim K (1976) Interaction of adrenergic antagonists with prostaglandin E2 and tetrahydrocannabinol in the eye. Invest Ophthalm 15:102–112

    Google Scholar 

  • Grinker RR (1964) Bootlegged ecstasy. JAMA 187:768

    Google Scholar 

  • Grinspoon L. Bakalar JB (1981) Psychedelic drugs reconsidered. Basic, New York

    Google Scholar 

  • Grob CS, Poland RE, Chang L, Ernst T (1996) Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behav Brain Res 73(1–2):103–107

    Google Scholar 

  • Grof S (1983) LSD-Psychotherapie. Klett-Cotta, Stuttgart

    Google Scholar 

  • Gröger D (1966) Fortschritte der Chemie und Biochemie der Mutterkornalkaloide. Fortschr Chem Forsch 6:159–164

    Google Scholar 

  • Gross D (1971) Vorkommen, Struktur und Biosynthese natürlicher Piperidinverbindungen. Fortschr Chem Org Naturstoffe 29:1–8

    Google Scholar 

  • Grotenthermen F (1999) Some practice-relevant aspects of the pharmacokinetics of THC. Forsch Komplementarmed 6Suppl 3:37–39

    Article  Google Scholar 

  • Grotenthermen F (2005) Cannabis und Cannabinoide. Hans Huber, Bern

    Google Scholar 

  • Grotenthermen F, Huppertz R (1997) Hanf als Medizin. Hang/Hüthig, Heidelberg

    Google Scholar 

  • Gruenwaldt G (1971) Haschisch, Marihuana, LSD — Eigenschaften, Bedeutung, Gefahren. Saarl Ärztebl 24:33–37

    Google Scholar 

  • Grupp SE (1972) Multiple drug use in a sample of experienced smokers. Int J Addict 7:481–491

    Google Scholar 

  • Gudelsky GA, Yamamoto BK, Nash JF (1994) Potentiation of 3,4-methylendioxymethamphetamine-induced dopamine release and sorotonin neurotoxicity by 5-HT2 agonists. Eur J Pharmacol 264:325–330

    Article  Google Scholar 

  • Haan J, Binder M (1980) Psychotrope Drogen: Halluzinogene und Psychostimulantien. Intern Welt 5:153–160

    Google Scholar 

  • Haenel TA (1970) Kulturgeschichte und heutige Problematik des Haschischs. Pharmakopsychiat Neuropsychopharmakol 3:89–115

    Google Scholar 

  • Hänsel W (1979) Struktur und Wirkung von Halluzinogenen. Chem in unserer Zeit 13:147

    Article  Google Scholar 

  • Hai H (1984) Das Hanfhandbuch. Piper, Löhrbach (Der grüne Zweig, Bd. 73)

    Google Scholar 

  • Haines JD (1998) Absinthe — Return of the green fairy. J Oklahoma State Med Assoc 91:406–407

    Google Scholar 

  • Halikas JA, Goodwin DW, Guze SB (1972) Marihuana use and psychiatric illness. Arch Gen Psychiatry 27:162–165

    Google Scholar 

  • Hallucinogenic and Psychedelic Drug Synthesis. Manual (1976) Salt and Pepper Syndicate. Lawrence/KS

    Google Scholar 

  • Hammer T, Vaglun P (1990) Initiation, continuation or discontinuation of cannabis use in the general population. Br J Addict 85:899–909

    Article  Google Scholar 

  • Hansjakob T (1999) Hanfshops — Gesundheitszentren oder Drogenumschlagplätze ? Kriminalistik 4:273–277

    Google Scholar 

  • Harding R, Knight F (1973) Marihuana-modified mania. Arch Gen Psychiatry 29:635–637

    Google Scholar 

  • Harner MJ (ed) (1973) Hallucinogens and shamanism. Oxford Univ Press, London

    Google Scholar 

  • Harvey DJ (1985) Marihuana 1984. IRL Press, Oxford

    Google Scholar 

  • Harzer K (1982) Nachweis von LSD in Körperflüssigkeiten mit Hochdruckflüssigkeitschromatographie. J Chromatogr 249:205–211

    Article  Google Scholar 

  • Hashimoto K et al. (1992) Effects of benzylpiperazine derivatives on the neurotoxicity of MDMA in rat brain. Brain Res 590/1–2: 341–344

    Article  Google Scholar 

  • Hasse HE, Waldmann H (1971) „Flashback“: Spontane psychotische Episoden als Folgeerscheinung des Phantasticagebrauchs Jugendlicher. Arch Psychiatr Nervenkr 214:399–439

    Article  Google Scholar 

  • Hawkes JG et al. (eds) (1979) The biology and taxonomy of the solanaceae. Academic Press, London

    Google Scholar 

  • Hawks RL (1982) The constituentes of cannabis and the disposition and metabolism of cannabinoids. Nat Int Drug Abuse Res Monogr Ser 42:125–137

    Google Scholar 

  • Heath RG (1976) Marihuana and delta 9 tetrahydrocannabinol: Acute and chronic effects an brain function of monkeys. In: Braude MC, Szara S (eds) Pharmacology of marihuana. Raven, New York, pp 345–356

    Google Scholar 

  • Heath RG, Fitzjarrell AT, Garey RE, Myers WA (1979) Chronic marihuana smoking: Its effets on function and structure of the primate brain. In: Nahas GG, Paton WDM (eds) Marihuana: Biological effects. Pergamon, New York, pp 713–730

    Google Scholar 

  • Hecker RM, Röhrich J, Neis P, Rittner C (2003) Phänomenologie der Akutwirkungen von „Partydrogen“ bei Diskothekenbesuchern. Blutalkohol 40:85–103

    Google Scholar 

  • Heim ME (1982) Cannabis und Cannabinoide. Fortschr Med 9:343–346

    Google Scholar 

  • Heim R (1967) Nouvelles investigations sur les champignons hallucinogènes. Editions des Musées Nationaux Histoire, Paris

    Google Scholar 

  • Heim R, Wasson RG (1958) Les champignons hallucinogènes du Mexique. Editions des Musées Nationaux Histoire, Paris

    Google Scholar 

  • Heimann H (1961) Ausdrucksphänomenologie der Modellpsychosen (Psilocybin). Psychiat Neurol 141:69–100

    Google Scholar 

  • Hein J, Lobbedey L, Neumärker KJ (2001) Absinth — Neue Mode, alte Probleme. Dtsch Ärztebl 98:2166–2171

    Google Scholar 

  • Heinemann C (1971) Klinisch beobachtete Folgeerscheinungen nach Haschischkonsum. Med Klin (Munich) 66:1648–1653

    Google Scholar 

  • Heinemann C (1973) Nachlassende Wirkung initialer Rauscherlebnisse und Dosissteigerung beim Haschischkonsumenten. Med Klin 68: 826–830

    Google Scholar 

  • Heinke DH (2004) Fahruntüchtigkeit aufgrund drogeninduzierter Einschränkung der Sehfähigkeit. Blutalkohol 41:241–246

    Google Scholar 

  • Heishman Sj, Singleton EG, Liguori A (2001) Marijuana craving questionnaire: development and initial validation of a self-report instrument. Addiction 96:1023–1034

    Article  Google Scholar 

  • Helmer R, Wunder R, Zellmann K, Haesen D (1972) Experimentelle Untersuchungen zur Fahrtüchtigkeit nach Einnahme von Haschisch. Blutalkohol 4:213–220

    Google Scholar 

  • Henderson GL (1988) Designer drugs, past history and future prospects. J Forensic Sci 33/2:569–575

    Google Scholar 

  • Henderson RL, Tennant FS, Guerry R (1972) Respiratory manifestations of hashish smoking. Arch Otolarnygol 95:248–251

    Google Scholar 

  • Henry JA (1999) Ecstasy and the dance of death. Brit Med J 305/7: 5–6

    Google Scholar 

  • Hepler RS, Frank IM (1971) Marihuana smoking and intraocular Pressure. JAMA 217:1392

    Article  Google Scholar 

  • Herer J (1993) Die Wiederentdeckung der Nutzpflanze Hanf-Cannabis-Marihuana. 2000, Frankfurt am Main

    Google Scholar 

  • Herha J (1974) Haschisch und Marihuana — eine Übersicht. Naturwissenschaften 61:90–94

    Article  Google Scholar 

  • Herning RI, Jones RT, Peltzmann DJ (1979) Changes in human event relate potentials with prolonged delta-9-tetrahydrocannabinol (THC) use. Electroencephalogr Clin Neurophysiol 47:556–570

    Article  Google Scholar 

  • Hermann TS, Einhorn LH, Jones SE, Nagy C, Chester AB et al. (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Eng J Med 300(23):1295–1297

    Article  Google Scholar 

  • Hesse M (1964/1968) Indolalkaloide in Tabellen. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Hesse M (1974) Progress in mass spectrometry, vol 1: Indolalkaloide. Verlag Chemie, Weinheim

    Google Scholar 

  • Hingson R, Alpert JS, Day N et a. (1982) Effects of maternal drinking and marihuana use on fetal growth and development. Pediatrics 70:539–546

    Google Scholar 

  • Hirschhorn K, Cohen MM (1968) Drug-induced chromosomal aberrations. Ann NY Acad Sci 151:977–987

    Google Scholar 

  • Hochman JS, Brill NQ (1973) Chronic marijuana use and psychosocial adaption. Am J Psychiatr 130:132–139

    Google Scholar 

  • Hoffer A, Osmond H (1967) The hallucinogens. Academic Press, New York

    Google Scholar 

  • Hoffmann D, Brunnemann KD, Gori GB, Wynder EL (1975) On the carcinogenicity of marijuana smoke. Res Adv Phytochem 9:63–81

    Google Scholar 

  • Hofmann A (1954) Die Isolierung weiterer Alkaloide aus Rauwolfia serpentina Benth. Helv Chim Acta 37:849–865

    Article  Google Scholar 

  • Hofmann A et al. (1958) Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe mexicana Heim. Experimentia XIV 3:107–112

    Article  Google Scholar 

  • Hofmann A (1960 a) Psychotomimetica, eine Übersicht. Svensk Kem Tidskr 72:79–88

    Google Scholar 

  • Hofmann A (1960 b) Die psychotropen Wirkstoffe der mexikanischen Zauberpilze. Chimia 14:309–318

    Google Scholar 

  • Hofmann A (1960 c) Isolierung von Lysergsäurealkaloiden aus der mexikanischen Zauberdroge Ololiuqui. Experimentia 16:414–420

    Article  Google Scholar 

  • Hofmann A (1961) Die Wirkstoffe der mexikanischen Zauberdroge Ololiuqui. Planta Med 9:354–367

    Google Scholar 

  • Hofmann A (1964) Die Mutterkornalkaloide. Enke, Stuttgart

    Google Scholar 

  • Hofmann A (1967) Psychoaktive Stoffe der Pflanzen. Therapiewoche 35: 40–47

    Google Scholar 

  • Hofmann A (1979) LSD — mein Sorgenkind. Klett-Cotta. Stuttgart.

    Google Scholar 

  • Hofmann A (1981) LSD ist eine sakrale Droge (Interview mit Dr. Hofmann). Psychol Heute 4:55–61

    Google Scholar 

  • Hofmannn A, Tscherter H (1960) Isolierung von Lysergsäurealkaloiden aus der mexikanischen Zauberdroge Ololiuqui. Experimantia XVI/9

    Google Scholar 

  • Hokkanen E, Waltimo O, Kallauranta J (1978) Toxic effects of ergotamine used for migraine. Headache 18:95–98

    Article  Google Scholar 

  • Höld KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE (2000) a-Thujone (the active component of absinthe): g-Aminobutyric acid type A receptor modulation and metabolic detoxification. Proc Natl Acad Sci USA 97:3826–3831

    Article  Google Scholar 

  • Hole G (1967) LSD und verwandte Halluzinogene. Geschichte — Wirkung — Gebrauch und Gefahren. MMW 109:1389–1397

    Google Scholar 

  • Hollister LE (1968) Chemical psychoses. LSD and related drugs. Thomas, Springfield/IL

    Google Scholar 

  • Hollister LE (1986) Health Aspects of Cannabis. Pharmacol Rev 38: 1–20

    Google Scholar 

  • Hollister LE, Gillespie HK, Ohlsson A (1981) Do plasma concentrations of Δ9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharm 21:171s–177s

    Google Scholar 

  • Hollister LE, Richards RK, Gillspie HK (1986) Comparison of Δ9-tetrahydrocannabinol and synhexyl in man. Clin Pharmacol Ther 9: 783–791

    Google Scholar 

  • Honecker HC, Coper C (1970) Dünnschichtchromatographische Nachweismethode von Opium als Beimengung in Haschisch-Proben. Dtsch Med Wochenschr 42:441–443

    Google Scholar 

  • Horowitz MJ (1969) Flashbacks: recurrent intrusive images after the use of LSD. Am J Psychiatry 126:147–151

    Google Scholar 

  • Huestis MA, Henningfield VE, Cane ED (1992) Blood Cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking Marihuana. J Anal Toxikol 16:276–282

    Google Scholar 

  • Huestis MA, Cone EJ (2004) Relationship of Delta-9-tetrahydrocannabinol concentrations in oral fluid ans plasma after controlled administration of smoked cannabis. J Anal Toxicol 28:394–399

    Google Scholar 

  • Hunt CA, Jones RT (1980) Tolerance and disposition of tetrahydrocannabinbol in man. J Pharm Exp Ther 215:35–44

    Google Scholar 

  • Hunt CA, Jones RT, Herning RI, Bachmann J (1981) Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man. J Pharmacokinet Biopharm 9:245–260

    Article  Google Scholar 

  • Huxley A (1972) The doors of perception (dtsch Übers: Die Pforten der Wahrnehmung. Piper, München)

    Google Scholar 

  • Isbell H, Gorodetzky CW, Jasinsky D, Claussen U. Spulak F, Korte F (1967) Effects of (-)-delta-9-transtetrahydrocannabinol in man. Psychopharmacologia (Berlin) 11:184–188

    Article  Google Scholar 

  • Iversen L (2003) Cannabis and the brain. Brain 126:1252–1270

    Article  Google Scholar 

  • Jacobson CB, Berlin CM (1972) Possible reproductive detriment in LSD users. JAMA 222:1367–1373

    Article  Google Scholar 

  • Jakubovic A, McGeer D (1972) Inhibition of rat brain protein by cannabinoids in vitro. Can J Biochem 50:654–660

    Article  Google Scholar 

  • Janowsky DS, Meacham MP, Blaine JD, Schoor M, Bozetti LP (1976 a) Simulated flying performance after marihuana intoxication. Aviat Space Environ Med 47:124–128

    Google Scholar 

  • Janowsky DS et al. (1976 b) Marijuana effects an simulated flying ability. Am J Psychiatry 133:384–388

    Google Scholar 

  • Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR et al. (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia. J Clin Oncology 20(2):567–573

    Article  Google Scholar 

  • Johannsson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK (1989) Terminal elimination plasma half-live of D-(1)-tetrahydrocannabinol (D(1)-THC) in heavy users of marijuana. Eur J Clin Pharmacol 37(3):273–277

    Article  Google Scholar 

  • Johns A (2001) Psychiatric effects of cannabis. Br J Psychiat 178:116–122

    Article  Google Scholar 

  • Johnson S, Domino EF (1971) Some cardiovascular effects of marihuana smoking in normal volunteers. Therapeutics 12:762–768

    Google Scholar 

  • Johnstone RE (1973) A Ketamine trip. Anesthesiol 39:460–461

    Article  Google Scholar 

  • Jones AB, ElSohly HN et al. (1984) Analysis of the Major Metabolite of Delta-9-tetrahydrocannabinol in Urine. An Comparison of Five Methods. J Anal Toxikol 8:249–251

    Google Scholar 

  • Jones H, Jones HC (1977) Sensual drugs. Cambrigde Univ Press, Cambridge

    Google Scholar 

  • Jones HC, Lovinger PW (1985) The marihuana question. Mead, New York

    Google Scholar 

  • Jones R (1977) Human effects. NIDA Res Monogr 14:128–178

    Google Scholar 

  • Joyce CRB, Currv SH (1970) The botany and chemistry of cannabis. Churchill, London

    Google Scholar 

  • Kandel D, Chen K (2000) Types of marihuana users by longitudinal course. J Stud Alcohol 61:367–378

    Google Scholar 

  • Kang S et al. (1970) Correlation between activity and electronic state of hallucinogenic amphetamines. Nature 226:645–647

    Article  Google Scholar 

  • Kannheiser W (2000) Mögliche verkehrsrelevante Auswirkungen von gewohnheitsmäßigem Cannabiskonsum. NZV 13:57–68

    Google Scholar 

  • Kanter SL, Hollister LE (1977) Marihuana metabolites in urine of man. Res Commun Chem Pathol Pharmacol 17:421–431

    Google Scholar 

  • Kaiser C, Gold R (1974) Perception, psychedelics and social change. J Psychedelic Drugs 6:30–35

    Google Scholar 

  • Kaplan HS (1971) Psychosis associated with marijuana. NY State J Med 71:433–435

    Google Scholar 

  • Karler R (1977) Toxicological and pharmacological effects. NIDA Res Monogr 14:55–66

    Google Scholar 

  • Karler R, Cely W, Turkanis SA (1974 a) Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids. Life Sci 15:931–947

    Article  Google Scholar 

  • Karler R, Cely W, Turkanis SA (1974 b) A study of the development of tolerance to an anticonvulsant effect of delta-9-THC and cannabidiol. Res Commun Chem Pathol Pharmacol 9:23–29

    Google Scholar 

  • Katzung W (1990) Drogen: Informationen in Übersichten IV. Abhängigkeit vom Cannabis-Typ. Leitdroge THC. Medizin aktuell 16: 568–570

    Google Scholar 

  • Katzung W et al. (1991) Psilocybe-Pilze-Drogen vor der Haustür? Medizin aktuell 17:654–655

    Google Scholar 

  • Katzung W, Harfst G (2001) Synthetische Amphetamin-Drogen. Holger Harfst Verlag, Würzburg

    Google Scholar 

  • Kaymakcalan S (1975) Potential dangers of cannabis. Int J Addict 10:721–735

    Google Scholar 

  • Keller K, Stahl E (1982) Kalmus: Inhaltsstoffe und Asarongehalt bei verschiedenen Herkünften. Dtsch Apoth Z 122/48:2463–2466

    Google Scholar 

  • Kelly P, Jones RT (1992) Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J Anal Toxicol 16:228–235

    Google Scholar 

  • Kemali M, Kemali D (1980) Lysergic acid diethylamide: Morphological study of its effects on synapsis. Psychopharmacol 69:315–317

    Article  Google Scholar 

  • Kemp PM, Abukhalaf JE, Manno BR et al. (1995) Cannabinoids in humans. I. Analysis of delta-9-tetrahydrocannabinol and six metabolits in urine using GC-MS. J Anal Toxicol 19:285–291

    Google Scholar 

  • Kennedy AB, Rätsch C (1985) Datura: Aphrodisiac? High Frontiers, Berkeley

    Google Scholar 

  • Keup W (1967) Psychotic symptoms due the cannabis abuse (a survey of newly admitted mental patients). Dis Nerv Syst 31:119–126

    Google Scholar 

  • Keup W (1990) Analoga kontrollierter Substanzen — Entwicklung des Missbrauchs in der BRD. Suchtgefahren 36:251–259

    Google Scholar 

  • Kielholz P, Hobi V, Ladewig D, Miest P, Richter R (1973) An experimental investigation about the effect of cannabis on car absorption. Pharmakopsychiatry 6:91–103

    Google Scholar 

  • Killestein J, Hoogervorst ELJ, Reif M, Kalkers NF, Van Loenen AC et al. (2002) Safety, tolerability and efficacy of orally administrated cannabinoids in MS. Neurology 58(9):1404–1407

    Google Scholar 

  • Kintz P, Cirimele V (1997) Testing human blood for cannabis by GC/MS. Biomed Chromatogr 11:371–373

    Article  Google Scholar 

  • Kintz P, Cirimele V, Ludes B (2000) Testing for cannabis in saliva of impaired drivers. Blutalkohol 37:89–92

    Google Scholar 

  • Kintz P, Girond C (1997) Immunoassay responses of MBDB. J Anal Toxicol 21:589–590

    Google Scholar 

  • Kleiber D, Kovar KA (1998) Auswirkungen des Cannabiskonsums. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Kleiner D (1992) Eine psychotische Episode mit Verkehrsunfall nach Cannabis-Konsum. Sucht 5:345–346

    Google Scholar 

  • Kleiner D, Stosberg K, Täschner K-L (1993) Erfahrungen mit Cannabiskonsumenten — Ergebnisse einer Umfrage bei Kliniken und Drogenberatungsstellen. Sucht 1:33–45

    Google Scholar 

  • Klonoff H (1974) Marihuana and driving in real-life situations. Science 32:317–323

    Article  Google Scholar 

  • Klonoff H (1983) Acute psychological effects of marihuana in man, including acute cognitive psychomotor and perceptual effects in driving. In: Fehr O’Brien K, Kalant H (eds) Cannabis and health hazards. Addiction Research Foundation, Toronto, pp 88–96

    Google Scholar 

  • Knapp H (1991) GABA ist an allem schuld. Suchtreport 5/2:28

    Google Scholar 

  • Knecht S (1962) Magische Pilze. Über die mexikanische Pilzzeremonie. Med Welt 35:1853–1859

    Google Scholar 

  • Kniesel M (1994) Nach der Entscheidung des BVerfG zur Strafbarkeit weicher Drogen. Anfang vom Ende der Drogenpolitik durch Strafrecht. ZRP 9:352–358

    Google Scholar 

  • Koch CAL (1864) Der Hanf. Allg Z Psychiatr 21:13–19

    Google Scholar 

  • Kolansky H, Moore WT (1971) Effects of marihuana on adolescents and young addults. JAMA 216:486–492

    Article  Google Scholar 

  • Konzett H (1981) Halluzinogene: LSD, Psilocybin und Mescalin. Dtsch Ärztebl 78:283–288

    Google Scholar 

  • Korte F et al. (1965) THC-Carbonsäure, ein neuer Haschisch-Inhaltsstoff. Angew Chem 77:33–35

    Google Scholar 

  • Kouri EM, Pope HG, Lukas SE (1998) Changes in aggressive behavior during withdrawal from long-term marijuana use. Human Psychopharmacol 8:483–492

    Google Scholar 

  • Kovar K-A (1989) Designer-Drugs — Synthetische Suchtstoffe der 2. Generation. In: Kath. Sozialethische Arbeitsstelle (Hrsg) Designer Drogen. Zum Gefährdungs-und Suchtpotential synthetischer Drogen. Hoheneck, Hamm

    Google Scholar 

  • Kovar K-A, Rösch C, Rupp A (1990) Synthetische Suchtstoffe der 2. Generation. 1. Mitt.: Amphetamine und andere Arylalkylamine. Pharm in unserer Zeit 19/3:99–107

    Article  Google Scholar 

  • Kraus L, Augustin R (2001) Repräsentativerhebung zum Gebrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland 2000. Sucht 47(1):5–82

    Google Scholar 

  • Krumsiek L (1975) Haschischöl. Kriminalistik 3:124–128

    Google Scholar 

  • Kuehne ME (1964) The total synthesis of vincamine. J Am Chem Soc 86: 2946–2973

    Article  Google Scholar 

  • Kuehnle J, Mendelson JH, Davis DR, New PFJ (1977) Computer tomographic examination of heavy marihuana smokers. JAMA 237/12: 1231–1232

    Article  Google Scholar 

  • Kumar S, Kunwar KB (1972) Chromosome abnormalities in cannabis addicts. J Assoc Phys India 19:193–195

    Google Scholar 

  • Kuntz M (1997) Mit Ecstasy auf der Suche nach dem verlorenen Glück — Du liebst alle und alle lieben Dich. Die Suchtarbeit mit Ecstasykonsumenten. Suchtreport 1:46–51

    Google Scholar 

  • Kutney JP, Brown RT, Piers E (1966) The absolute configuration of the Iboga alkaloids. Can J Chem 44:637–645

    Article  Google Scholar 

  • Kunert HJ (Hrsg) (1999) Cannabis. Das unterschätzte Kraut. Ariadne, Aachen

    Google Scholar 

  • Kvalseth TO (1977) Effects of marihuana on human reaction time and motor control. Percept Mot Skills 45:935–939

    Google Scholar 

  • LaBarre W (1960) Twenty years of peyote studies. Curr Anthropol 1: 45–60

    Article  Google Scholar 

  • LaBarre W (1972) Hallucinogens and the shamanic origin of religion. In: Furst P T (ed) Flesh of the Gods: The ritual use of hallucinogens. Praeger, New York, pp 36–49

    Google Scholar 

  • La Valle S (1984) Hashish. Quarter Books, London New York Melbourne

    Google Scholar 

  • Law B (1984) Confirmation of cannabis use by the analysis of △9-THC metabolits in blood and urine by combined HPLC and RIA. J Anal Toxicol 8:19–22

    Google Scholar 

  • Law B, Mason PA, Moffat AC et al. (1984) Forensic Aspects of the Metabolism and Excretion of Cannabinoids Following Oral Ingestion of Cannabis Resin. J Pharm Pharmacol 36:289–294

    Google Scholar 

  • Law FCP (1980) Metabolic disposition and potential toxicity of PCC in rats. Res Comm in Subst of Abuse 1/3:273

    Google Scholar 

  • Leaf RC, De Bold RC (1967) LSD, man and society. Wesleyan Univ Press, Connecticut

    Google Scholar 

  • Leary T (1962) How to change behaviour. (Proceedings of XIV. International Congress on Applied Psychology, Copenhagen)

    Google Scholar 

  • Leary T (1964) The religious experience. Psychedelic Rev 3:30–42

    Google Scholar 

  • Leary T (1970) Politik der Ekstase. Wegner, Hamburg

    Google Scholar 

  • Leistenfels H von (oJ) Pilze: Speisepilz-Zucht Rauschpilz-Erkennung. Pieper & Die Grüne Kraft, Löhrbach (Grüner Zweig, Bd 65)

    Google Scholar 

  • Lemberger L, Silberstein SD, Axelrod J, Kopin IJ (1970) Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man. Science 170:1320–1322

    Article  Google Scholar 

  • Lemberger L, Rubin A (1975) The physiologic disposition of marihuana in man. Life Sci 17:1637–1642

    Article  Google Scholar 

  • Leonhardt RW (1970) Haschischreport. Piper, München

    Google Scholar 

  • Leuenburger H (1969) Zauberdrogen. Goverts, Stuttgart

    Google Scholar 

  • Leuner H (1971) Halluzinogene in der Psychotherapie. Pharmakopsychiatry 4:333–351

    Google Scholar 

  • Leuner H (1981) Halluzinogene. Huber, Bern

    Google Scholar 

  • Levy JA, Munson AE, Harris LS, Dwewey WL (1975) Effects of delta-9-THC on the immune response of mice. Fed Proc 34:782–789

    Google Scholar 

  • Lewin L (1927) Phantastica — Die betäubenden und erregenden Genußmittel (Nachdruck 1981). Volksverlag, Linden

    Google Scholar 

  • Lewin L (1929) Banisteria Caapi. Stilke, Berlin

    Google Scholar 

  • Lewis EG, Peters BA, Dustman RE, Straight RC, Beck EC (1976) Sensory, perceptual, motor and cognitive functioning and subjective reports following oral admimistration of delta-9-THC. Psychopharmacologia (Berlin) 47:141–148

    Article  Google Scholar 

  • Liden CB, Lovejoy FH, Castello CE (1975) Phencyclidine — 9 Cases of Poisoning. JAMA 234/5:513–516

    Article  Google Scholar 

  • Lidz T, Rothenberg A (1970) Psychedelismus: Die Wiedergeburt des Dionysos. Psyche 24:359–374

    Google Scholar 

  • Liechti ME, Gamma A, Vollenweider FX (2001) Gender difference in the subjektive effects of MDMA. Psychopharmacol (Berlin) 154(2):161–168

    Article  Google Scholar 

  • Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders. Arch Gen Psychiatry 51:273–279

    Google Scholar 

  • Lockwood TE (1979) The ethnobotany of brugmansia. J Ethnopharmacol 1:147–164

    Article  Google Scholar 

  • Löhrer F (1997) Biogene Suchtmittel. Ariadne, Aachen

    Google Scholar 

  • Ludlow FH (1981) Der Haschisch-Esser. Sphinx, Basel

    Google Scholar 

  • Luisada PV, Brown BJ (1976) Clinical Management of Phencyclidine Psychosis. Clin Toxicol 9/4:539–545

    Google Scholar 

  • Lundberg GD, Gupta RC, Montgomery SH (1976) Phencyclidine: Patterns Seen in „Street Drug“ Analysis. Clin Toxicol 9/4:503–511

    Google Scholar 

  • Lyon RA et al. (1986) MDMA Stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacol 88:525–526

    Google Scholar 

  • Madsen W (1955) Shamanism in Mexico. Southwest J Anthropol 2/1:48–57

    Google Scholar 

  • Manden M, Skopp G, Mattern R, Aderjan R (2000) GC/MS-Bestimmung von THCCOOH im Serum: Vergleich verschiedener Aufarbeitungsmethoden und Einfluß von THCCOOH-Glucuronid. Blutalkohol 37:48–56

    Google Scholar 

  • Manno JE, Kiplinger GF, Haine SE, Bennett IF, Forney RB (1970) Comparative effects of smoking marihuana or placebo on human motor and mental performance. Clin Pharmacol Ther 11:808–815

    Google Scholar 

  • Margolis JS, Clorfene R (1979) Der Grassgarten. Volksverlag, Linden

    Google Scholar 

  • Marijuana and Health (1980) 8th Annual Report to the US Congress from the Secretary of Health, Education and Welfare, Washington/DC

    Google Scholar 

  • Marzell H (1964) Zauberpflanzen — Hexengetränke. Kosmos 241:47–55

    Google Scholar 

  • Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418(6897):530–534

    Article  Google Scholar 

  • Mason AP, McBay AJ (1984) Ethanol, marijuana and other drugs in 600 drivers killed in single-vehicle crashes in North-Carolina 1978–1981. J Fornsic Sci 29:987–1026

    Google Scholar 

  • Mason AP, McBay AJ (1985) Cannabis. Pharmacology and Interpretation of effects. J Forensic Sci 30:615–631

    Google Scholar 

  • Mattes RD, Shaw LM, Edling-Owens J et al. (1993) Bypassing the first-pass effect for the therapeutic use of the cannabinoids. Pharmacol Biochem Behav 44:745–747

    Article  Google Scholar 

  • McBay AJ (1985) Marijuana testing and litigation. J Forensic Sci 30: 987–994

    Google Scholar 

  • McBay AJ (1988) Interpretation of Blood and Urine Cannabinoid Concentrations. J Forensic Sci 33:875–883

    Google Scholar 

  • McBurney LJ, Bobbie BA, Sepp LA (1986) GC/MS and EMIT Analyses for Delta-9-Tetrahydrocannabinol Metabolites in Plasma and Urine of Human Subjects. J Anal Toxicol 10:55–64

    Google Scholar 

  • McCann UB, Ridenour A, Graham Y, Ricaurte G (1994) Serotonin Neurotoxicity after MDMA (‘Ecstasy’): A controlled Study in Humans. Am Coll of Neuropsychopharmacol 2:129–138 9

    Google Scholar 

  • McCullum NK, Shaw SM (1981) Chromatographic analysis for Δ9-tetrahydrocannabinol in blood and brain. J Anal Toxicol 5:148–149

    Google Scholar 

  • McDonald PA, Martin CF, Woods DJ, Baker PB, Gough TA (1984) An analytical study of illicit lysergide. J Forensic Sci 29:120–130

    Google Scholar 

  • McGee R, Williams S, Poulton R, Moffitt T (2000) Longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 95:491–503

    Article  Google Scholar 

  • McGlothlin WS, Cohen S, McGlothlin M (1964) Short-term effects of LSD on anxiety, attitudes and performance. J Nerv Ment Dis 139: 266–273

    Article  Google Scholar 

  • McGlothlin WS, Cohen S, McGlothlin M (1970) Long lasting effects of LSD on normals. J Psychedelic Drugs 3:20–31

    Google Scholar 

  • McLeary JA, Sypherd PS, Walkington DJ (1960) Antibiotic activity of an extract of peyote Lophophora williamsii (Lemaire) Coulter. Econ Bot 14:247–249

    Google Scholar 

  • Meatherall RC, Warren RJ (1993) High urinary cannabinoids from a hashish body packer. J Anal Toxicol 17:439–440

    Google Scholar 

  • Mechoulam R (1970) Marihuana chemistry. Science 168:1159–1166

    Article  Google Scholar 

  • Mechoulam R (1973) Marihuana-Chemistry, pharmacology, metabolism and clinical effects. Academic Press, London

    Google Scholar 

  • Mechoulam R, Gaoni Y (1965) A total synthesis of d,1-delta-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273–3275

    Article  Google Scholar 

  • Mechoulam R et al. (1994) Search for endogenous ligands of the cannabinol receptor. Biochem Pharmacol 48:1537–1540

    Article  Google Scholar 

  • Mechoulam R, Panikasshvili D, Shohami E (2002) Cannabinoids and brain injury: therapeutic implications. Tends Molecular Medicine 8:58–61

    Article  Google Scholar 

  • Meck B (1981) Die Assassinen. Econ, Düsseldorf Wien

    Google Scholar 

  • Melges FT, Tinklenberg JR, Hollister LE, Gillespie HK (1970) Marihuana and temporal disintegration. Science 6:1118–1120

    Article  Google Scholar 

  • Mendelsohn JH (ed) (1974) The use of marihuana. Plenum, New York

    Google Scholar 

  • Mendelsohn JH (1987) Marijuana. In: Meltzer HY (ed) Psychopharmakology, Raven, New York, pp 60–67

    Google Scholar 

  • Merkus F et al. (1971) TLC, GLC, MS of cannabidivarin, tetrahydrocannabivarin and cannabivarin. Acta Pharm Suec 8

    Google Scholar 

  • Merritt JC, Perry DD, Russell DN, Jones BF (1981) Topical delta-9-tetrahydrocannabinol and aqueous dynamics in glaucoma. J Clin Pharmacol 21(8–9 Suppl):467–471

    Google Scholar 

  • Miller LL (ed) (1974) Marijuana — effects on human behavior. Academic Press, New York San Francisco London

    Google Scholar 

  • Miller LT, Cornett T, McFarland D (1978) Marijuana: an analysis of storage and retrieval deficits in memory with the technique of restricted reminding. Pharmacol Biochem Behav 8:327–332

    Article  Google Scholar 

  • Miller RA (1983) The magical and ritual use of herbs. Destiny, New York

    Google Scholar 

  • Moeller MR, Doerr G, Watts S (1992) Simultaneous quantitation of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in serum by GC/MS using deuterated internal standards and its application to a smoking stydy and forensic cases. J Forensic Sci 37:969–983

    Google Scholar 

  • Möller MR, Kauert G, Tönnes S, Schneider E, Theunissen EL, Ramaekers JG (2006) Leistungsverhalten und Toxikokinetik der Cannabinoide nach inhalativer Marihuanaaufnahme. Blutalkohol 43:361–375

    Google Scholar 

  • Möller-Nehring E, Luderer H-J (1997) Ist die Angst vor Ecstasy berechtigt? Fortschr Med 7:28–34

    Google Scholar 

  • Morgan MJ, McFie L, Fleetwood LH, Robinson JA (2002) Ecstasy (MDMA): Are the psychological probleme associated with ist use reversed by prolonged abstinence? Psychopharmacol 159:294–303

    Article  Google Scholar 

  • Morton JF (1981) Atlas of medical plants of middel america. Thomas, Springfield/IL

    Google Scholar 

  • Moskowitz H, Sharma S, McGlothlin WS (1972) Effetcs of marihuana upon peripheral vision as a function of the information processing demand in central vision. Percept Mot Skills 35:876–882

    Google Scholar 

  • Moskowitz H, McGlothlin WS (1974) Effects of marihuana on auditory signal detection. Psychopharmacologia (Berlin) 48:137–145

    Article  Google Scholar 

  • Munch JC (1974) Phencyclidine: Pharmakology and Toxicology. Bull Narc 26/4:9–17

    Google Scholar 

  • Mura P, Kintz P, Dumestre V, Raul S, Haue T (2005) THC can be detected in brain while absent in blood. J Anal Toxicol 29:842–843

    Google Scholar 

  • Murray JB (1985) Marihuana’s Effects on Human Cognitive Functions, Psychomotor Functions, and Personality. J Gen Psychol 113:23–55

    Article  Google Scholar 

  • Myerhoff BG (1980) Der Peyote Kult. Trikont, München

    Google Scholar 

  • Naef M, Russmann S, Petersen-Felix S et al. (2004) Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans. J Pharm Sci 93(5):1176–1184

    Article  Google Scholar 

  • Nahas GG (1972) Toxicology and pharmacology of cannabis sativa with special reference to delta-9-THC. Bull Narc 24:11–27

    Google Scholar 

  • Nahas GG (1974) Effects of cannabis and cannabinoids on cell replication and replication and DNA synthesis in man. J Pharmacol 5: 71–78

    Google Scholar 

  • Nahas GG (1975) Marihuana — Deceptive Weed. Raven Press, New York

    Google Scholar 

  • Nahas GG (1979) Keep off the grass. Pergamon, Oxford New York

    Google Scholar 

  • Nahas GG (1982) Hashish in Islam, 9th to 18th century. Bull NY Acad Med 58/9:814–831

    Google Scholar 

  • Nahas GG (ed) (1984) Marihuana in science and medicine. Raven, New York

    Google Scholar 

  • Nahas GG (1986) Cannabis: toxicological properties and epidemiological aspects. Med J Anst 145:82–87

    Google Scholar 

  • Nahas GG (1991) Es ist doch nur Marihuana. Suchtreport 5/2:18–27

    Google Scholar 

  • Nahas GG, Patton WDM (eds) (1979) Marihuana. Biological effects analysis, metabolism, cellular responses, reproduction and brain. Pergamon, Oxford

    Google Scholar 

  • Nahas GG, Sucia-Foca N, Armand J-P, Morishima A (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science 183: 419–420

    Article  Google Scholar 

  • Nahas GG, Desoize B, Hsu J, Morishima A, Srinvasan PR (1975) Inhibition of nucleic acid and poteins synthesis by natural cannabinoids and olivetol. (Abstract, IV. Int. Congress of Pharmacology, Helsinki, p 495)

    Google Scholar 

  • Nahas GG, Patton WDM, Idänpään Heikkilä JE (eds) (1976) Marihuana: chemistry, biochemistry and cellular effects. Springer, New York

    Google Scholar 

  • Nahas GG, Latour Z (1992) The human toxicity of marihuana. Med J Anst 156/7:495–497

    Google Scholar 

  • Nakamura GR, Meeks RD, Stall WJ (1990) Solid-Phase Extraction, Identification and Quantitation of 11-nor-Delta-9-Tetrahydrocannabinol-9-carboxylic Acid. J Forensic Sci 35:792–796

    Google Scholar 

  • Negrete JC (1973) Psychological adverse effects of cannabis smoking. A tentative classification. Can Med Assoc J 108:195–196

    Google Scholar 

  • Negrete JC, Knapp WP (1996) The effects of cannabis use on the clinical condition of schizophrenics. NIDA Res Monogr 67:321–327

    Google Scholar 

  • Neu RL, Powes HO, King S, Gardner LI (1969) Cannabis and chromosomes. Lancet I:675

    Article  Google Scholar 

  • Neumeyer JL, Shagoury L (1971) Chemistry and pharmacology of marijuana. J Pharm Sci 60:1433–1451

    Article  Google Scholar 

  • Neuninger H (1988) Zur Bewertung von inländischen Cannabis-Produkten. Österr RichterZ 66:127–130

    Google Scholar 

  • Nichols DE, Hoffmann AJ, Oberlender RA et al. (1986) Derivats of 1-(1,3-Benzodioxol-5-yl-butanamine): Representatives of a Novel Therapeutic Class. J Med Chem 29(10): 2009–2015

    Article  Google Scholar 

  • Nichols WW, Miller RC, Heneen W, Bradt C, Hollister L, Kanter S (1974) Cytogenetic studies on human subjects receiving marihuana and delta-9-tetrahydrocannabinol. Mutat Res 26:413–417

    Google Scholar 

  • Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J (2001) Detection of Marijuana Use by Oral Fluid and Urine Analysis Following Single-Dose Administration of Smoked and Oral Marijuana. J Anal Toxicol 25:289–303

    Google Scholar 

  • Niedbala RS, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ (2004) Passive Cannabis Smoke Exposure and Oral Fluid Testing. J Anal Toxicol 28:546–552

    Google Scholar 

  • Nolte F (2002) Cannabis im Straßenverkehr — Zur Inszenierung und Dramaturgie eines gesellschaftlichen „Problems“. Blutalkohol 39(Suppl. 1):17–20

    Google Scholar 

  • Novotny M, Lee MC, Keast D (1976) A possible chemical basis for the higher mutagenicity of marihuana smoke as compared to tobacco smoke. Experientia 32:280–282

    Article  Google Scholar 

  • Nowlan R, Cohen S (1977) Tolerance to marihuana: heart rate and subjective „high“. Clin Pharmacol Ther 22:550–555

    Google Scholar 

  • Noyes R (1975) The analgesic properties of delta-9-THC and codeine. Clin Pharmacol Ther 18:84–89

    Google Scholar 

  • Obrocki J, Buchert R, Vaterlein O, Thomasius R et al. (1999) Ecstasy-long-term effects on the human central nervous system revealed by positron emission tomography. Br J Psychiatry 175:186–188

    Article  Google Scholar 

  • O’Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylendioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788–2803

    Google Scholar 

  • Ohlsson A, Lindgren JE, Wahlen A et al. (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28: 409–416

    Article  Google Scholar 

  • Ohlsson A, Lindgren JE, Wahlen A et al. (1982) Single dose kinetics of deuterium labeled delta-1-tetrahydrocannabinol in heavy and light cannabis users. Biomed Mass Spectrom 9:6–10

    Article  Google Scholar 

  • Olson RW (2000) Absinthe and g-aminobutyric acid receptors. Proc Natl Acad Sci USA 97:4417–4418

    Article  Google Scholar 

  • Olvedi U (1972) LSD-Report. Suhrkamp, Frankfurt am Main

    Google Scholar 

  • Orzechowski G (1969) Halluzinogene Drogen, Med Welt 16:955–963

    Google Scholar 

  • Oss OT, Oeric ON (1976) Psilocybin, magic mushrooms grower’s guide. And/Or Press, Berkeley

    Google Scholar 

  • Ott J (1976) Hallucinogenic plants of North America. Wingbow, Berkeley/CA

    Google Scholar 

  • Ott J, Bigwood J (eds)(1978) Teonanacatl: Hallucinogenic mushroom of North America. Madrona, Seattle/WA

    Google Scholar 

  • Pace HD, Davis A, Borgen LA (1971) Teratogenesia and marihuana. Ann NY Acad Sci 191:123–128

    Article  Google Scholar 

  • Pahnke W (1963) Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness. Master’s thesis Univ of Harvard

    Google Scholar 

  • Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacol (Berlin) 139(3):261–268

    Article  Google Scholar 

  • Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W (2002) Cannabi use and mental health in young people: cohort study. Br Med J 325:1195–1198

    Article  Google Scholar 

  • Patzak J, Marcus A, Goldhausen S (2006) Cannabis — wirklich eine harmlose Droge? NStZ 5:259–266

    Google Scholar 

  • Patzak J, Goldhausen S (2007) Der aktuelle Wirkstoffgehalt von Cannabis. NStZ 4:195–198

    Google Scholar 

  • Payne RJ, Brand SN (1975) The toxicity of intravenously used marihuana. JAMA 233:351–354

    Article  Google Scholar 

  • Peeke SC, Jones RT, Stone GC (1976) Effects of practice an marihuana — induced changes in reaction time. Psychopharmacol 48: 159–163

    Article  Google Scholar 

  • Peel HW, Perrigo BJ (1981) Detection of cannabinoids in blood using EMIT. J Anal Toxicol 5:165–167

    Google Scholar 

  • Perez-Reyes M, Owens SM, DiGuiseppe S (1981) The clinical pharmacology and dynamics of marihuana cigarette smoking. J Clin Pharmacol 21:201s–207s

    Article  Google Scholar 

  • Perez-Reyes M, DiGuiseppe S, Davis KH et al. (1982) Comparisation of effects of marihuana cigarettes of three different potencies. Clin Pharmacol Ther 31:617–624

    Article  Google Scholar 

  • Peronka S, Newman M, Harris H (1988) Subjective Effects of DOM in Recreational Users. Neuropsychopharmacol 1:273–277

    Google Scholar 

  • Perontka SJ (ed)(1990) Ecstasy, the clinical, pharmacological and neurotoxicological effects of the drug MDMA. Khiver Academic Publishers, Boston

    Google Scholar 

  • Pertwee RG (2001) Cannabinoid receptors ans pain. Progress Neurobiology 63(5):569–611

    Article  Google Scholar 

  • Petersen BH, Graham J, Lembeger L (1976) Marihuana, tetrahydrocannabinol and T-cell function. Life Sci 19:395–400

    Article  Google Scholar 

  • Petersen RC (ed)(1977) Marihuana research findings. NIDA Res Monogr 14:205–218

    Google Scholar 

  • Petersen RC (ed) (1980) Marijuana research findings. NIDA Res Monogr 31:69–85

    Google Scholar 

  • Petersen RC, Stillman RC (1978) Phencyclidine (PCP) abuse: An appraisal. NIDA Res Monogr 21:168–175

    Google Scholar 

  • Petro DJ, Ellenberger C (1981) Treatment of human spasticity with delta-9-THC. J Clin Pharmacol 21:413–416

    Google Scholar 

  • Petrzilka T (1971) Chemie synthetischer Hanf-Derivate. Bull Schweiz Akad Med Wiss 27:22–27

    Google Scholar 

  • Petrzilka T, Haefliger W, Sikemeier G, Ohloff G, Eschenmoser A (1967) Synthese und Chiralität des (-)-Cannabidiols. Helv Chim Acta 50: 719–723

    Article  Google Scholar 

  • Peuckert W-E (1960) Hexensalben. Med Monatsspiegel 9:169–174

    Google Scholar 

  • Piomelli D, Giuffrida A, Calingnano A, de Fonseca FR (2000) The endocannabinoid system as a target for the therapeutic drugs. Trends Pharmacol Sciences 21:218–224

    Article  Google Scholar 

  • Poehlke T (1995) MDMA — Droge oder Medikament? Westfäl Ärztebl 8: 16–19

    Google Scholar 

  • Pope HG (2002) Cannabis, cognition and residual confounding. JAMA 287(9):1172–1174

    Article  Google Scholar 

  • Pope HG, Gruber AJ, Hudon JI, Huestis MA, Yurgelun-Todd D (2001) Neuropsychological performance in long-term Cannabis users. Arch Gen Psychiatry 58:909–915

    Article  Google Scholar 

  • Pope HH Jr (1969) Tabernanthe iboga — an African narcotic plant of social importance. Econ Bot 23:174–184

    Google Scholar 

  • Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90(1):45–60

    Article  Google Scholar 

  • Priemer F, Grappmaier A, Ruby M et al. (1999) Pupillenverhalten unter akutem THC-Einfluß. Blutalkohol 32:84–98

    Google Scholar 

  • Rabes M, Harm W (Hrsg)(1997) XTC und XXL: Ecstasy-Wirkungen, Risiken, Vorbeugungsmöglichkeiten und Jugendkultur. Rowohlt, Reinbek

    Google Scholar 

  • Rätsch C (1995) Die Grüne Fee: Absinth in der Schweiz. Jahrbuch für Ethnomedizin und Bewusstseinsforschung 4:285–287

    Google Scholar 

  • Rätsch C (1998) Enzyklopädie der psychoaktiven Pflanzen: Botanik, Ethnopharmakologie und Anwendung. AT Verlag

    Google Scholar 

  • Raffauf RF, Flagler MB (1960) Alkaloids of the apocynaceae. Econ Bot 14:37–46

    Google Scholar 

  • Rakete G, Flüsmeier U (1997) Der Konsum von Ecstasy. Eine empirische Studie zu Mustern und psychosozialen Effekten des Ecstasykonsums. Bundeszentrale für gesundheitliche Aufklärung, Köln.

    Google Scholar 

  • Ramaekers JG, Kauert G, Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR (2006) High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control. Neuropsychopharmacol 1–8

    Google Scholar 

  • Randall T (1992) „Rave“ Scene, Ecstasy Use, Leap Atlantic. JAMA 268: 1506–1509

    Article  Google Scholar 

  • Ranke-Graves R von (1985) Griechische Mythologie. Rowohlt, Reinbek

    Google Scholar 

  • Ray R, Prabhu GG, Mohan D, Nath LM, Neki JS (1978) Cannabis use. The association between chronic abuse and cognitive functions. Drug Alcohol Depend 3:365–368

    Article  Google Scholar 

  • Rayner R (1979) Pilze erkennen — leicht gemacht. Franck’sche Verlagsbuchhandlung, Stuttgart

    Google Scholar 

  • Reed A, Kane W (1972) Phencyclidine (PCP). J Psychedelic Drugs 5/1: 8–12

    Google Scholar 

  • Reeve VC, Grant JD, Robertson W et al. (1983 a) Plasma concentration of delta-9-tetrahydrocannabinol and impaired motor function. Drug Alcohol Depend 11:176–175

    Google Scholar 

  • Reeve VC, Robertson WB, Grant J (1983 b) Hemolyzed blood and serum levels of δ9-THC: Effects on the performance of roadside sobriety tests. J Fornesic Sci 28:963–971

    Google Scholar 

  • Remschmidt H (1972) Haschisch und LSD. Physische und psychische Wirkungen. Med Klin 67:706–716, 781–786

    Google Scholar 

  • Renault PF, Schuster CR, Heinrich R, Freeman DX (1971) Marihuana: Standartized smoking administration and dose effects on heart rate in humans. Science 174:589–591

    Article  Google Scholar 

  • Reynolds PC (1976) Clinical and Forensic Experiences with Phencyclidine. Clin Toxicol 9/4:547–552

    Article  Google Scholar 

  • Ricklin F (1989) Cannabis: harmloses Rauschgift? Schweiz Med Wochenschr 119:1173–1176

    Google Scholar 

  • Rivier L, Lindgren J-E (1972) Ayahuasca — South American hallucinogenic drink: ethnobotanical and chemical investigations. Econ Bot 24:100–129

    Google Scholar 

  • Robinson TE, Castaneda E, Wislaw IQ (1993) Effects of cortical serotonin depletion induced by 3,4-methylendioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade. Neuropsychopharmacol 8(1):77–85

    Google Scholar 

  • Robson O (2001) Therapeutic aspects of cannabis and cannabinoids. Br J Psychiat 178:107–115

    Article  Google Scholar 

  • Rösch C et al (1990) Synthetische Suchtstoffe der 2. Generation. 2. Mitt.: Analytik der Arylalkylamine. Pharm in unserer Zeit 19/5: 211–221

    Article  Google Scholar 

  • Rodin E, Domino E, Porzak J (1970) The marijuana induced social high — Neurological and electroencephalographic concomitants. JAMA 213:1300–1202

    Article  Google Scholar 

  • Rosenthal E (1984) Marijuana beer. And/Or Press, Berkeley

    Google Scholar 

  • Safford WE (1916) Identity of cohoba, the narcotic snuff of ancient Haiti. J Wash Acad Sci 6:548–562

    Google Scholar 

  • Sahihi A (1989) Designer-Drogen: die neue Gefahr. Beltz, Weinheim Basel

    Google Scholar 

  • Sahihi A (1991) Designer-Drogen: Zwischen Hölle und Paradies. Suchtreport 5/1:42–47

    Google Scholar 

  • Sallan SE, Zinberg NE, Frei E (1975) Antiemetic effect of delta-9-THC in patients receiving cancer chemotherapy. N Eng J Med 293: 795–797

    Article  Google Scholar 

  • Sankar DVS (1975) LSD — A total study. PJD Publications, Westbury/NY

    Google Scholar 

  • Sankar DVS, Roszy PW, Geisler A (1969) Chromosome breakage in children treated with LSD-25 und UML-491. Compr Psychiatry 10: 406–410

    Article  Google Scholar 

  • Saunders N (1994) „Ecstasy“. Bilger, Zürich

    Google Scholar 

  • Saxton JE (1956) The indole alkaloids excluding harmine and strychnine. Q Rev 10:108–112

    Article  Google Scholar 

  • Scherer S (1996) Cannabis als Genußmittel? ZRP 5:187–191

    Google Scholar 

  • Schleifer H (1973) Sacred narcotic plants of the New World Indians. Hafner, New York

    Google Scholar 

  • Schmidt D (1970) Halluzinogene aus Pflanzen. Naturwiss Rundschau 23:5

    Google Scholar 

  • Schmidt P, Scheer N, Berghaus G (1995) Cannabiskonsum und Fahrtüchtigkeit. Kriminalistik 4:241–246

    Google Scholar 

  • Schmiechen R et al. (1986) Carbolines — A new class of compounds with high affinity for benzodiazepine receptors. Sonderdruck: IXth Int. Symposium on Medicinal Chemistry, Berlin

    Google Scholar 

  • Schmitt G, Herbold M, Aderjan R (1999) Berechung der Nachweis-, der Erfassungs-und der Bestimmungsgrenze von Tetrahydrocannabinol (THC) im Serum. Blutalkohol 36:362–370

    Google Scholar 

  • Schönhofer PS (1973) Die Pharmakologie der Cannabis-Wirkstoffe. Arzneimittelforsch 23:50–55

    Google Scholar 

  • Schreiber LH (1997) Das Urteil des BGH zu Ecstasy. NJW 12:777–779

    Google Scholar 

  • Schreiber LH (2005) Die Bewertung von THC-Spuren bei Verurteilung wegen Drogenfahrt. NJW 15:1026–1027

    Google Scholar 

  • Schrenk T von (1999) Internistische Komplikationen nach Ecstasy. Dtsch Ärztebl 96:A-347–352

    Google Scholar 

  • Schultes RE (1941) A contribution to our knowledge of rivea corymbosa, the narcotic ololiuqui of the Aztecs. Harvard Botanical Museum, Cambrigde/MA

    Google Scholar 

  • Schultes RE (1965) Ein halbes Jahrhundert amerikanischer Ethnobotanik der Halluzinogene. Planta med 13:125–129

    Google Scholar 

  • Schultes RE (1969) Hallucinogens of plant origin. Science 163: 245–254

    Article  Google Scholar 

  • Schultes RE (1969/70) The plant kingdom and hallucinogens. Bull Narc 21:3–16, 22:25–53

    Google Scholar 

  • Schultes RE (1970 a) The botanical and chemical distribution of hallucinogens. Ann Rec Plant Physiol 21:571–590

    Article  Google Scholar 

  • Schultes RE (1970 b) Botany and chemistry of cannabis. Churchill, London

    Google Scholar 

  • Schultes RE (1972) An overview of hallucinogens in the western hemisphere. In: Furst P T (ed) Flesh of the Gods: The ritual uses of hallucinogens. Praeger, New York, pp 3–54

    Google Scholar 

  • Schultes RE (1976) Hallucinogenic plants. Golden Press, New York

    Google Scholar 

  • Schultes RE, Hofmann A (1980) The botany and chemistry of hallucinogens. Thomas, Springfield/IL

    Google Scholar 

  • Schultes RE, Hofmann A (1995) Pflanzen der Götter. Die magischen Kräfte der Rausch-und Giftgewächse. AT, Aarau

    Google Scholar 

  • Schultz OE, Haffner C (1958) Zur Kenntnis eines sedativen Wirkstoffes aus dem deutschen Faserhanf. Arch Pharm (Berlin) 291:20–24

    Article  Google Scholar 

  • Schulz V (1984) Behandlung des Ergotismus. Fortschr Med 8:189–190

    Google Scholar 

  • Schurz J (1970) Vom Bilsenkraut zum LSD. Frank’sche Verlagsbuchhandlung, Stuttgart

    Google Scholar 

  • Schuster P, Wittchen H-U (1996) Ecstasy-und Halluzinogengebrauch bei Jugendlichen. Gibt es eine Zunahme? Verhaltenstherapie 6:222–223

    Google Scholar 

  • Schwarz CJ (1968) The complications of LSD: a review of the literature. J Nerv Ment Dis 146:174–186

    Article  Google Scholar 

  • Sharma S, Moskowitz H (1972) Effect of marihuana on the visual autokinetic phenomenon. Percept Mot Skills 35:891–894

    Google Scholar 

  • Shulgin AT, MacLean DE (1976) Illicit Synthesis of Phencyclidine (PCP) and several of its Analogs. Clin Toxicol 9/4:553–560

    Google Scholar 

  • Shulgin AT, Shulgin A (1991) PIKHAL: A chemical love story. Transform press, Berkeley, CA

    Google Scholar 

  • Sigrist T, Germann U, Sutter K (1998) Intoxikation mit Stechapfelgift (Scopolamin). Kriminalistik 3:219–221

    Google Scholar 

  • Silverman J (1968) Shamans and acute schizophrenia. Am Anthropol 69: 21–31

    Article  Google Scholar 

  • Simon NG, Mattick RP (2002) The impact of regular ecstasy use on memory functions. Addiction 97:1523–1529

    Article  Google Scholar 

  • Skopp G, Pötsch L (2001) Zur Passivexposition bei der Beurteilung niedriger Cannabinoidkonzentrationen im Blut und Urin. Arch Kriminol 207(5–6):137–147

    Google Scholar 

  • Skopp G, Dettling A, Pötsch L, Schmitt G, Haffne HAT (2003) Begleitstoffprofile Absinthhaltiger Bitterspirituosen. Blutalkohol 40:287–293

    Google Scholar 

  • Smith MV (1981) Psychedelic chemistry. Loompanics Unlimited Mason/USA (Nachdruck des 1973 in Rip Off Press erschienenen Werkes)

    Google Scholar 

  • Smith NT (2002) A review of the published literature into cannabis withdrawal symptoms in human users. Addiction 97:621–632

    Article  Google Scholar 

  • Smith PB et al. (1994) The Pharmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice. J of Pharmacol 270: 219–220

    Google Scholar 

  • Smith RN, Robinson K (1985) Body fluid levels of lysergide (LSD). Forensic Sci Int 28:229–237

    Article  Google Scholar 

  • Snyder SH (1967) STP: a new halluzinogenic drug. Science 158:669–712

    Article  Google Scholar 

  • Solowij NS, Stephens RS, Roffmann RA, Babor T. Kadden R et al. (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287(9):1123–1131

    Article  Google Scholar 

  • Soueif MI (1976) Differential association between chronic cannabis use and brain function deficits. Ann NY Acad Sci 282:323–343

    Article  Google Scholar 

  • de Souza E, Battaglia G, Insel T (1990) Neurotoxic Effects of MDMA on Brain Serotonin Neurons: Evidence from Neurochemical and Radioligand Binding Studies. Ann NY Acad Sci 6:682–698

    Article  Google Scholar 

  • Soyka M et al. (1993) Zur Phänomenologie einer ketamininduzierten Psychose. Sucht 39/5:327–331

    Google Scholar 

  • Spanos LJ, Yamamoto BK (1989) Acute and subchronic effects of methylenedioxymethamphetamine (MDMA) on locomotion and serotonin Syndrome behaviour in rat. Pharmacol Biochem Behav 32:835–840

    Article  Google Scholar 

  • Stafford P (1980) Enzyklopädie der psychedelischen Drogen. Volksverlag, Linden

    Google Scholar 

  • Stahl E et al. (1978) Rauschgiftpilze mit LSD? Arch Krim 162(1/2):23

    Google Scholar 

  • Stanton MD, Mintz J, Franklin RM (1976) Drug flashbacks. II: Some additional findings. Int J Addict 11:53–69

    Google Scholar 

  • Starks M (1979) Marijuana potency. And/Or Press, Berkeley

    Google Scholar 

  • Steckel R (oJ) Bewußtseinserweiternde Drogen. Haschisch — Marihuana — LSD — Meskalin — STP(DOM) — Psilocybin — Ololiuqui. Edition Voltaire

    Google Scholar 

  • Stefanis C, Dornbush R, Fink M (1977) Hashish-studies of long-term use. Raven, New York

    Google Scholar 

  • Stenchever MA, Kunysz TJ, Allen MA (1974) Chromosome breakage in users of marihuana. Am J Obstet Gynecol 118:106–113

    Google Scholar 

  • Stevens A (2002) Cannabis und Cannabinoide als Medizin. Sucht 48:329–335

    Google Scholar 

  • Stoll WA (1947) Lysergsäureamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz Arch Neurol Psychiatr 60:279–323

    Google Scholar 

  • Stoll WA (1952) Recent investigations on ergot alkaloids. Fortschr Chem Org Naturst 9:114–119

    Google Scholar 

  • Stosberg K, Lösch H (1987) Haschisch-Spätfolgen. Suchtreport 5:13–16

    Google Scholar 

  • Stowe BB (1959) Occurence and metabolism of simple indoles in plants. Fortschr Chem Org Naturst 17:248–252

    Google Scholar 

  • Strang J, Arnold WN, Peters T (1999) Absinthe: what’s your poison? Brit Med J 319:1590–1592

    Google Scholar 

  • Stringaris MG (1972) Die Haschischsucht. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Stromberg VL (1954) The Isolation of bufotenin from Piptadenia peregrina. J Am Chem Soc 76:170–171

    Article  Google Scholar 

  • Sullivan AT, Twitchett PJ, Fletcher SM, Moffat AC (1978) The fate of LSD in the body: forensic considerations. J Forensic Sci 18: 89–98

    Google Scholar 

  • Svrcek M (1979) Der Kosmos-Pilzführer. Frank’sche Verlagsbuchhandlung, Stuttgart

    Google Scholar 

  • Swatek R (1984) Marijuana use: Persistence and urinary elimination. J Substance Abuse Treatment 1:265–270

    Article  Google Scholar 

  • Täschner K-L (1980) Haschisch für alle? Hess Ärztebl 7 (Sonderdruck)

    Google Scholar 

  • Täschner K-L (1981) Das Haschischproblem aus klinischer Sicht. Dtsch Ärztebl 78:126–129

    Google Scholar 

  • Täschner K-L (1983) Zur Psychopathologie und Differentialprognose sogenannter Cannabispsychosen. Fortschr Neurol Psychiatr 51: 235–248

    Google Scholar 

  • Täschner K-L (1986) Das Cannabisproblem — Haschisch und seine Wirkungen. Deutscher Ärzte-Verlag, Köln

    Google Scholar 

  • Täschner K-L, Wanke K (1975) Zur Frage der toxischen Psychose am Beispiel der sog. LSD-Psychose. Fortschr Med 31:1515–1518, 1542

    Google Scholar 

  • Täschner K-L, Frießen DH (1989) Verkehrstauglichkeit bei Rauschgiftkonsumenten unter besonderer Berücksichtigung des Cannabismißbrauchs. Suchtgefahren 35:253–262 (Sonderdruck)

    Google Scholar 

  • Tarshis MS (1972) The LSD controversy — an overview. Thomas, Springfield/IL

    Google Scholar 

  • Tashkin DP (1987) Marijuana-Bronchitis. Am Rev Resp Dis 135:209

    Google Scholar 

  • Tashkin DP, Simmons M, Clark V (1988) Effect of habitual smoking of marijuana alone and with tobacco on nonspecific airways hyperreacticity. J Psychoactive Drugs 20:21–25

    Google Scholar 

  • Taylor FM (1988) Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J 81:1213–1216

    Google Scholar 

  • Taylor WI (1966) Indole alkaloids, an introduction to the enamine chemistry of natural products. Pergamon, New York

    Google Scholar 

  • Teitelbaum DT, Wingeleth DC (1977) Diagnosis and management of recreational mescaline poising. J Anal Toxicol 1:36–37

    Google Scholar 

  • Tennant FS, Groesbeck CJ (1972) Psychiatric effects of Hashish. Arch Gen Psychiatry 27:133–136

    Google Scholar 

  • Tennant FS, Preble M, Prendergast TJ, Ventry P (1971) Medical manifestations associated with Hashish. JAMA 216:1965–1969

    Article  Google Scholar 

  • Tenscher E, Lindenquist U (1994) Biogene Gifte. Gustav-Fischer

    Google Scholar 

  • Teuchert-Noodt G, Bagorda F (2002) Drogen-induzierte Destabilisierung psycho-kognitiver Leistungen als Gefahr für den Straßenverkehr — Wie sich Ecstasy und andere Drogen in das Gehirn einschreiben, und die Frage nach den Chancen einer Therapie. Blutalkohol 39(Suppl. 1):21–31

    Google Scholar 

  • Thamm BG (1987a) Alltagsdroge Haschisch. Suchtreport 1/4:2–7

    Google Scholar 

  • Thamm BG (1987b) Synthetische Drogen. Suchtreport 1/3:52–54

    Google Scholar 

  • Thamm BG (1990) Pflanzen der Götter. Suchtreport 4/3:48–57

    Google Scholar 

  • Theale JD, Forman EF, King LJ (1975) The development of a radioimmunassay for cannabinoids in blood and in urine. J Pharm Pharmacol 27:465–472

    Google Scholar 

  • Thomas WR, Holt PG, Keast D (1974) Recovery of immune system after cigarette smoking. Nature 248:358–359

    Article  Google Scholar 

  • Thomasius R (Hrsg.)(1999) Ecstasy-Wirkungen, Risiken, Interventionen. Ein Leitfaden für Klinik und Praxis. Enke, Stuttgart

    Google Scholar 

  • Thomasius R (Hrsg.)(2000) Ecstasy: Eine Studie zu gesundheitlichen und psychosozialen Folgen des Missbrauchs. Wiss Verlagsges, Stuttgart

    Google Scholar 

  • Thomasius R et al. (1997) MDMA („Ecstasy“)-Konsum — ein Überblick zu psychiatrischen und medizinischen Folgen. Fortschr Neurol Psychiatr 65:49–61 (Sonderdruck)

    Google Scholar 

  • Thomasius R, Jarchow C (1997) „Ecstasy“: Psychotrope Effecte, Komplikationen, Folgewirkungen. Dtsch Ärztebl 94A:372–376 (Sonderdruck)

    Google Scholar 

  • Thomasius R, Petersen KU, Küstner U, Wartberg L, Zeichner D (2004) Cannabis als Medikament — eine Nutzen/Risiko-Abwägung. Blutalkohol 9:383–400

    Google Scholar 

  • Toennes SW, Kauert GF (2002) Pharmakokinetische Simulation der Plasmakonzentration von Δ9-tetrahydrocannabinol (THC) nach oraler Aufnahme von Hanföl. Blutalkohol 39:237–243

    Google Scholar 

  • Tong TG, Benowitz NL, Becker CE, Forni PJ, Boerner U (1975) Phencyclidine Poisoning. JAMA 234/5:572–573

    Article  Google Scholar 

  • Tossmann HP (1997) Ecstasykonsummuster, Konsumkontexte und Komplikationen. Ergebnisse der Ecstasy-Infoline. Sucht 43:121–129

    Google Scholar 

  • Tossmann HP, Boldt S, Tensil MD (2001) The use of drugs within the techno party scene in European metropolitan cities. Eur Addict Res 7(1):2–23

    Article  Google Scholar 

  • Treffert DA (1978) Marihuana use in schizophrenia: a clear hazard. Am J Psychiatry 135:1213–1215

    Google Scholar 

  • Ungerleider JT et al. (1968) The „bad trip“ — the etiology of the adverse LSD reaction. Am J Psychiatry 124:1483–1490

    Google Scholar 

  • Vierth G (1967) Psycho-pathologische Syndrome nach Haschischgenuß. MMW 1:522–528

    Google Scholar 

  • Vogel R, Matthiessen W, Bruckner O, Alexander M (1981) Lungenkomplikationen bei Rauschgiftsucht. Prax Pneumol 35:988–991

    Google Scholar 

  • Van Peteghen C, Heyndrickx A, Van Zelle W (1980) GLC-mass spectral determination of mescaline in plasma of rabbits after intravenous injection. J Pharm Sci 69:118–120

    Article  Google Scholar 

  • Völger G (Hrsg.) (1982) Rausch und Realität, Drogen im Kulturvergleich, Bde 1—3. Rowolth, Reinbek (Materialienband zur Ausstellung des Rautenstrauch-Joest-Museums für Völkerkunde der Stadt Köln 1981, Teil 1 und 2)

    Google Scholar 

  • Vogt DD (1981) Absinthium: A Nineteenth-Century Drug of Abuse. J Ethnopharmacol 4(3):337–342

    Article  Google Scholar 

  • Vogt DD, Montagne M (1982) Absinthe: Behind the Emerald Mask. Intern J Addictions 17(6):1015–1029

    Google Scholar 

  • Wall ME, Perez-Reyes M (1981) The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 21: 178s–189s

    Google Scholar 

  • Wall ME, Sadler BM, Brine D et al. (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34(3):352–363

    Article  Google Scholar 

  • Waser P (1971) Pharmakologische Wirkungsspektren von Halluzinogenen. Bull Schweiz Akad Med Wiss 27:39–57

    Google Scholar 

  • Wasson RG (1959) The hallucinogenic mushrooms of Mexiko. Academy of Science, New York

    Google Scholar 

  • Wasson RG (1962) The hallucinogenic mushrooms of Mexiko and psilocybin: a bibliography. Bot Mus Leafl Harv Univ 20:20–73

    Google Scholar 

  • Wasson RG (1968) Soma. Divine mushroom of immortality. Harcourt Brace Jovanovich, New York

    Google Scholar 

  • Wasson RG, Hofman A, Ruck CAP (1978) The road to Eleusis: Unveiling the secrets of the mysteries. Harcourt Brace Jovanovich, New York

    Google Scholar 

  • Wasson VP, Wasson RG (1957) Mushrooms. Russia and history. Pantheon, New York

    Google Scholar 

  • Wax RH, Wax ML (1962) The magical world view. J Sci Study Rel 1: 179–188

    Article  Google Scholar 

  • Wehner HD, Wildemann H, Köhling R (2006) Quantitative Pharmakokinetik der passiven THC-Aufnahme. Blutalkohol 43:349–360

    Google Scholar 

  • Weidmann H, Taeschler M, Konzett H (1958) Zur Pharmakologie von Psilocybin, einem Wirkstoff aus Psilocybe mexicana Heim. Experentia 14:378–379

    Article  Google Scholar 

  • Wells B (1974) Psychedelic drugs. Penguin, Baltimore

    Google Scholar 

  • Whites SC, Brin SC, Janicki BW (1975) Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers. Science 188: 71–72

    Article  Google Scholar 

  • Whiting JD, Manders WW (1982) Confirmation of Tetrahydrocannabinol Metabolite in Urine by Gas Chromatography. J Anal Toxicol 6:49–52

    Google Scholar 

  • Widmann M, Agurell S, Ehrnbo M, Jones G (1974) Binding of (+)-Δ1-and (-)-Δ1-tetrahydrocannabinols and (-)-7-hydroxytetrahydrocannabinol in blood cells and plasma proteins in man. J Pharm Pharmacol 26:914–916

    Google Scholar 

  • Williams EG, Himmelsbach CK, Wikler A, Ruble D C, Lloyd BJ Jr (1964) Studies on marijuana and parahexyl compund. Public Health Rep 61:1059–1084

    Google Scholar 

  • Williams PL, Moffat AC (1980) Identification in human urine of delta-9-tetrahydrocannabinol-11-oc acid glucuronide: a tetrahydrocannabinol metabolite. J Pharm Pharmacol 32:445–448

    Google Scholar 

  • Winterfeldt E (1971) Neuere Aspekte in der Chemie der Indolalkaloide. Chimia 25:394–396

    Google Scholar 

  • Winterfeldt E (1974) Stereoselektive Totalsynthese von Indolalkaloiden. Fortschr Chem Org Naturst 31:469–472

    Google Scholar 

  • Woggon B (1974) Haschisch — Konsum und Wirkung. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Yago KB, Pitts FN Jr, Burgoyne RW et al. (1981) The urban epidemie of phencyclidine (PCP) use. J Clin Psychiatry 42:193–196

    Google Scholar 

  • Yesavage JA et al. (1985) Carry-over effects of marihuana intoxication on aircraft pilot performance. Am J Psychiatry 142: 1325–1329

    Google Scholar 

  • Zellweger H, McDonald JS, Abbo G (1967) Is isoergicacid diethylamide a teratogen? Lancet 7525:1066–1068

    Article  Google Scholar 

  • Zimmermann AM, Ray AY (1980) Influence of cannabinoids on somatic cells in vivo. Pharmacol 21:277–287

    Google Scholar 

  • Zimmermann S, Zimmermann AM, Cameron IL, Laurence HL (1977) Delta-9-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice. Pharmacol 15:10–23

    Article  Google Scholar 

  • Zinck R, Möller D (Hrsg.) (1998) Designer-Drogen vom Amphetamin-Typ „Ecstasy“. Abbott, Wiesbaden

    Google Scholar 

  • Zingg C, Bovens M (2000) „Ecstasy“-Tabletten und deren kriminalpolizeiliches Auswertungspotenzial. Kriminalistik 12:833–838

    Google Scholar 

  • Züger V (1974) Eine neue Form von Haschisch. Haschisch-Öl. Kriminalistik 18/3:129

    Google Scholar 

  • Zschockelt A (1986) Die „nicht geringe Menge“ Cannabis — Problematik der THC-Bestimmung. MDR 6:457–459

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2007). Psychodysleptica. In: Rauschdrogen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72045-4_2

Download citation

Publish with us

Policies and ethics

Search

Navigation